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1I. Introduction
Condoms have long been used to prevent disease and pregnancy. Many people, but not all, support ending
the spread of sexually transmitted diseases (“STDs”) and a signiﬁcant reduction in unwanted pregnancy
rates. Condom opponents dispute the extent to which condoms are the solution to these two problems.
While some condom opponents argue that abstinence is the only viable method to prevent disease and
pregnancy, other opponents at least question the extent to which sexually active teenagers and adults should
rely on condoms’ eﬀectiveness and whether the Food and Drug Administration has the obligation to label
condoms in a more conservatively to better disclose risks inherent in condom use.
The public use of condoms to prevent disease and pregnancy can have two possible opposing eﬀects. On one
hand, condoms can prevent bad outcomes associated with each act of risky sex, and on the other, condom use
can promote more acts of risky sex (by making people less fearful about bad consequences). One question
is how to weigh the two factors together. For instance, if condoms are 1% eﬀective, but lead to a 300%
increase in risky conduct, then the net increase in overall risk is (.99)(3.0) = 2.97, or a 197% increase. In
that case, encouraging condoms as a preventive might increase STD transmission rates, in addition to any
“moral harm” caused increased promiscuity. Now, say condoms are 90% eﬀective, and lead only to a 10%
increase in risky sex. Then, the net change is risk is (.1)(1.1) =.11, which is a 89% decrease. Even considering
the second scenario, a society may not approve of condoms if it feels that the increase in risky sex is moral
unacceptable, or if it feels that bad outcomes are the right price to pay for immorality.
Thus, debates over promoting or allowing condom use raise questions of whether bad outcomes (unwanted
pregnancy, disease) are increased or decreased, apart from the inherent morality of non-marital sex. Over the
2last two decades, the FDA position on condoms has traditionally assumed the ﬁrst scenario, that condom use
on the whole reduces the STD rates. The FDA’s position has been in accord with the widespread scientiﬁc
consensus. However, under increasing political pressure from pro-abstinence conservatives over the last ﬁve
year, the FDA may be shifting its view closer towards the second scenario and adopting a more caution
approach in regulating condoms. Such pressure is exempliﬁed by the recent movement toward including
warning labels on condoms packaging.
Given the lack of certainty whether condoms are an eﬀective public health solution, the political debate
becomes focused upon values and morality. As Linda Gordon, Professor of History at New York University
who specializes in examining the historical roots of contemporary social policy debates, argues,1 even today,
debates over reproductive rights are political, rather than scientiﬁc conﬂicts. Thus, Gordon claims that
even technological developments and facially neutral scientiﬁc discoveries must be understood in political
context. The key political question is: Should two consenting adults have the freedom to choose traditionally
“immoral” sexual behaviors such as non-marital and non-procreative sex. Historically, such immorality
carried risks of suﬀering that served as disincentives. The conservative fear is that once the disincentive is
removed, society will drown in an ocean of licentiousness and vice.
As other more eﬀective forms of birth control are widely used, the debate over condoms has shifted to their
eﬀectiveness in preventing disease. Condoms are the only method, apart from abstinence, that may prevent
transmission of certain STDs.
This paper surveys the history of condom use, the underlying science, the FDA regulation of condoms
and the recent debate on condoms and their eﬀectiveness in preventing disease. In articulating the debate,
perspectives of the Catholic Church are propounded as examples of arguments hinging exclusively on religious
1Linda Gordon, Moral Property of Women, at vii (Univ. of Ill. Press 2002).
3moral premises. The Church’s perspectives are revealing in the way that they shape so called “medical” or
“scientiﬁc” recommendations against condom use. Accordingly, this paper explores the conclusions of social
conservatives that, assuming condoms should be prohibited; the key alternative is abstinence and chastity.
II. Historical Perspectives and Scientiﬁc Underpinnings: The Early Years
Egyptian art dating back to 1350 B.C. depicts males who have barriers covering the tip of the penis.2 In
actuality, however, such barriers were used, not as contraceptives, but as protection against tropical diseases
or insect bites, as insignia of rank or status, as decorations or for clothing.3 It was a small step from these
penis-speciﬁc coverings to modifying them for use to prevent pregnancy or STDs.4
As early as the 16th century, condoms were used for the prevention of infection,5 providing evidence non-
marital promiscuous sexual activities were key facilitators of this innovation. The ﬁrst written description of
the condom and its utility is found in De morbo gallico, written by the great Italian anatomist and syphilis
expert Fallopius.6 Fallopious described the condom as a linen sheath that is cut to cover the head of the
penis and worn to prevent against “French Caries” or syphilis infection. 7 Fallopius explained that he had
“tried the experiment on eleven hundred men, and ...call[ed] immortal God to witness that not one of them
was infected.”8 While Fallopius noted its convenience (men could carry sheaths in their pocket), an early
2Norman E. Himes, Medical History of Contraception 186 (Williams & Wilkins 1936).
3Id. Today, by way of comparison, the highland inhabitants of West Papua, Indonesia, wear elab-
orate penis gourds. One can see pictures of these penis gourds, similar to those used in Egypt, at
http://www.rhymer.net/New%20Folder/penisgourdgallery/gallery.htm.http://www.rhymer.net/New%20Folder/penisgourdgallery/gallery.htm
4Himes, supra note 3, at 186.
5Id. at 187.
6Id. at 188.
7Id. at 188-190.
8Id. at 190.
418th century physician noted its disadvantages:
...the Condum being the best, if not the only Preservative our Libertines have found out
at present; and yet by reason of its blunting the Sensation, I have heard some of them
acknowledge, that they had often chose to risk a Clap, rather than engage cum Hastis sic
clypeatis. [With spears thus sheathed.]”9
Condoms were not used for contraception until as late as the 18th century.10 Condom merchants in 18th
century England printed bill board advertising condoms as “implements of safety.”11 The bills used the
following blurb – “To guard yourself from shame or fear, Votaries to Venus, hasten here, None in our ware
e’er found a ﬂaw, Self-preservation’s nature’s law.”12 Casanova, writing extensively about condoms,13 called
the devices “The English Riding Coat,” “preservative sheaths” and “assurance caps.”14 He used condoms
not only to prevent pregnancy, but also to avoid STDs.15 For instance, before having sex with a “public
woman” with whom he was concerned with the risk of acquiring a STD, he would insist that she oﬀer him
a condom.16 Similar to modern testing techniques, Casanova would inﬂate his condoms with air to check
whether it had any holes or weaknesses.17
The key innovation in condom technology occurred when the Vulcanization of rubber was discovered by
Goodyear and Hancock in 1843.18 The use of vulcanized rubber, as opposed to animal tissue, lowered costs
and increased condom quality. Literally hundreds of publications, treatises and handbills attested to the
utility of this new invention.19 Today’s latex condom is a direct descendant of the vulcanized rubber condom
10Himes, supra note 3, at 187.
11Id.
12Id. at 200, citing F. Grose, Guide 12 (1796).
13Himes, supra note 3, at 195.
14Id.
15Id.
16Id.
17Id.
18Id. at 201.
19Id.
5that took the world by storm in the 19th century.
A condom is the only reversible male contraceptive method. It is a thin sheath of latex, plastic or lambskin20
that covers the penis during intercourse.21 22 Condoms work as contraceptives by collecting semen and
other male secretions that may contain sperm and thus preventing the insemination of the woman.23 For
the condom to achieve its beneﬁcial purpose it must not break, slip or otherwise allow sperm to pass the
latex barrier. In order to achieve its maximum preventive capacity, the condom must also be used correctly
and consistently.24 Condoms, including the material they are made from, are engineered so as to be easily
placed on the penis, to contain the collected ﬂuid and to minimize breakage and slippage.25
Rubber condoms have been mass-produced since the 19th century26 and are widely used today both in the
United States and internationally. In 1995, approximately 13% of women of reproductive age reported using
condoms for contraception.27 Young men aged ﬁfteen through nineteen showed that only 9.5% had never
used condoms.28 However, despite being widely used, few people prefer using condoms as contraception.29
20A small proportion (about 5% in the US) are made of the intestinal caecum of the lamb. Murphy JS: The condom
industry in the US (McFarland and Company, Inc. 1990). These natural membrane or “lambskin” condoms are not as
eﬀective as contraceptives or as disease prevention devices. See id.
21Planned Parenthood, Federation of America, Inc., The Condom, at http://www.plannedparenthood.org/pp2/portal/ﬁles/portal/medicalinfo/birthcontrol/pub-
condom.xml (last visited May 23, 2005).
2221 C.F.R. § 884.5300 (2004) (“A condom is a sheath which completely covers the penis with a closely ﬁtting membrane.
The condom is used for contraceptive and for prophylactic purposes (preventing transmission of venereal disease). The device
may also be used to collect semen to aid in the diagnosis of infertility.”)
23Planned Parenthood, supra note 22, at http://www.plannedparenthood.org/pp2/portal/ﬁles/portal/medicalinfo/birthcontrol/pub-
condom.xml.
24Nat’l Inst. of Allergy and Infectious Diseases, Nat’l Inst. of Health, US Dept. of Health and Human
Svcs., Workshop Summary, Scientiﬁc Evidence on Condom Eﬀectiveness for Sexually Transmitted Disease Prevention, at 6,
available at http://www.niaid.nih.gov/dmid/stds/condomreport.pdf (last visited May 23, 2005) [hereinafter Scientiﬁc Evidence
on Condom Eﬀectiveness].
25http://www.niaid.nih.gov/dmid/stds/condomreport.pdfId. at 26.
26Jeﬀerson, Id. [HBS article, Gallo paper]
27Abma JC, Chandra A, Mosher WD, Peterson LS, Piccinino LJ. Fertility, family planning, and women’s health: new data
from the 1995 National Survey of Family Growth. Vital Health Stat 1997;23:1-114. (Cited in MF Gallo et al, Contraception
68 (2003) 319-326.
28Sonenstein Fl et al., Changes in Sexual Behavior and Condom Use Among Teenaged Males: 1988 to 1995, 88 Am. J.
Public Health 956, 956-959 (1998).
29Erin T McNeil et al., Family Health International, Monograph, The Latex Condom: Recent Advances, Future
Directions, at ch. 2, available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/condomaccept.htm.
6For instance, only 5% of married women of reproductive age use condoms as contraception.30
III. Condom Reliability
Contraception
Condoms are safe, eﬀective, user-controlled, non-prescription, easy to use and relatively cheap. As contra-
ceptives, condoms have a perfect-use failure rate of 3% and a typical use failure rate31 of 14%.32 This means
if one hundred women use condoms for a year, three will be pregnant assuming each used the condom per-
fectly. Typical use, however, would theoretically yield fourteen pregnant women.33 Signiﬁcant variations in a
condom’s eﬀectiveness for preventing pregnancy arise from whether the condom is correctly and consistently
used.34 The average failure rate is likely closer to 14% rather than 3% because of the various negative senti-
ment concerning condoms that discourages correct and consistent use. Such negatives decreased sensitivity
and sexual enjoyment. Three-quarters of men surveyed in the United States allege that condoms decrease
pleasurable sensation.35 Given the wide availability of more pleasurable, non-barrier contraception such as
the pill, people are reluctant to use condoms if they perceive, even inaccurately, that they are at a low risk
for contracting an STD.36 Requesting that a partner use a condom also can be embarrassing. Condoms
30Id.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/condomaccept.htm
31Id. These rates refer to the risk that a woman will become pregnant in her ﬁrst year of use, assuming perfect use
(consistently) and typical use. For example, less than half of condom users report using condoms consistently at every act of
intercourse. Id.
32R.A. Hatcher et al., Contraceptive Technology (17th ed., Ardent Media Inc. 1998).
33“Typical use” entails either a properly executing the instructions and properly using the condom during each sexual
encounter.
34McNeil, supra note 30, at ch. 1 available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htm.
35Other factors include: reducing sensation, requiring care to avoid breakage, requiring withdrawing quickly, embarrassing to
buy, diﬃcult to put on, often comes oﬀ during sex, embarrassing to discard, indicates that partner requesting to use the condom
either has HIV or an STD or believes that the other partner has HIV or an STD. W.R. Grady et al., Condom Characteristics:
The Perceptions and Preferences of Men in the U.S., 25 Family Planning Perspectives, at 67-73 (1993).
36McNeil, supra note 30, at ch. 1, available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htm.
http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/condomaccept.htm
7are sometimes not easy to apply and remove during sex; they may ﬁt uncomfortably tight during sex,37
and allergies may prevent the use of latex condoms. For these reasons, both male and female partners are
sometimes reluctant to agree to correct and consistent condom use during sex.
When used correctly, condoms as medical devices are highly reliable contraceptives. A 10% pregnancy rate in
typical use does not mean condoms fail 10% of the time.38 Human factors by far account for most pregnancies
as opposed to product defects in condoms. According to Family Health International, studies show that the
inconsistent and incorrect use of condoms is a far greater explanatory factor for pregnancy than is condom
failure (breakage and slippage).39 Mathematical models of inconsistent use and condom failure conﬁrm this
result. When condoms do fail because of apparent product defects, such failures are also generally the result
of the user’s behavior or physical, mental or sociological characteristics.40 Not surprisingly, those who have
experienced condom failure are twice as likely to experience it again as compared to those who have no
experience with condom failure.41 Accordingly, in a study of forty-four Nevada prostitutes who had sex
41,000 times, one woman reported that 41% of condoms she used broke while three reported that 47% of
condoms each used slipped.42
User characteristics that have been studied for association with failure include: history of failure, less expe-
rience with condom use, youth, less education, larger penis and/or circumcised penis. User behaviors that
have been studied for links with condom failure include: (i) opening condom packages with sharp objects,
37M.F. Gallo et al., Non-latex vs. Latex Male Condoms for Contraception: A Systematic Review of Randomized Controlled
Trials, 68 Contraception, at 319-326 (2003).
38McNeil, supra note 30, at ch.1, available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htm.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htm
39http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htmId.
40Id. Using oil as a lubricant (it destroys latex) during sex or having anal sex would be an ex-
ample of user behavior that promotes condom failure. Having a genital piercing or long ﬁngernails
that rip latex would be a user attribute that results in condom failure. Id. at ch. 3, available at
http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/behavcharac.htm.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/behavcharac.htm
41See id.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/behavcharac.htm
42A.E. Albert et al., Condom use among female commercial sex workers in Nevada’s legal brothels, 85 Am. J. Public Health
1514, 1514-1520 (1995).
8(ii) unrolling the condom before donning, (iii) lengthy or vigorous sex, (iv) using too much lubrication, (v)
reducing natural vaginal lubrication by drying agents, (vi) engaging in anal and/or oral intercourse, (vii) en-
gaging in intercourse in speciﬁc unnatural positions and/or (viii) re-using condoms.43 More detailed research
is needed to understand precisely which behaviors and user characteristics contribute most signiﬁcantly to
higher rates of condom failure in some users. Perhaps some practices, such as using oil-based lubrication or
employing sharp objects to open condom wrappers, might be addressed through improved package labeling.
It is unknown (but perhaps an interesting research question) whether counseling or instruction could reduce
condom failure rates that some users experience.
Figure 1
Inconsistent condom use contributes more to pregnancy than condom failure44
(derived from Family Health International)
Disease Prevention
43McNeil, supra note 30, at ch. 3, available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/behavcharac.htm.
44See id. at ch. 1, available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htm.
9Condoms also may reduce the risk of contracting sexually transmitted infection by preventing contact with
infectious secretions and skin lesions. Condoms, when used correctly and consistently, are eighty ﬁve through
100% eﬀective in preventing the transmission of HIV, the virus that causes AIDS. Studies show that in
relationships containing one HIV positive partner consistent condom use is extremely eﬀective in preventing
transmission of the virus with zero to two persons infected for every one hundred persons per year of
exposure,45 implying a near-zero risk of infection. Such studies, however, also indicate that inconsistent
condom use yields a similar risk of infection as a person that does not use condoms at all.46 Though
studies are not as advanced, condoms’ eﬃcacy in preventing other sexually transmitted infections, such as
gonorrhea, syphilis, Chlamydia, chancroid, trichomoniasis, HPV, herpes (HSV), and pelvic inﬂammatory
disease is probable.
In Vitro testing shows that condoms are “virtually certain” of blocking passage of genital ﬂuids between
partners.47 Scanning electron microscope pictures show pits and imperfections but no pores that cross
the entire membrane.48 FDA researchers have created a test model for condom leakage using a highly
concentrated solution of a laboratory virus.49 While this test is not routinely used to test condoms, it is
perhaps more sensitive and therefore more precise than the conventional water leakage test. Using this
test model, FDA scientists testing many diﬀerent types of condoms found that condoms were very eﬀective
45Planned Parenthood, supra note 22, at http://www.plannedparenthood.org/pp2/portal/ﬁles/portal/medicalinfo/birthcontrol/pub-
condom.xml, citing Alberto Saracco et al., Man-To-Woman Transmission of HIV: Longitudinal Study of 343 Steady Partners
of Infected Men, 6 Journal of Acquired Immune Deficiency Syndromes, at 497-502 (Raven Press Ltd., New York 1993);
also Isabelle De Vincenzi, Heterosexual Transmission of HIV in European Cohort of Couples, European Centre for
the Epidemiological Monitoring of AIDS (Paris, France 1993), reported in, U.S. Centers for Disease Control and
Prevention, Morbidity and Mortality Weekly Report 42, at 30 (Aug. 6, 1993).
46These results reinforce the point that perhaps most bad outcomes that occur with condom use are due
to condoms not being used correctly and consistently. See McNeil, supra note 30, at ch.1, available at
http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htm.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htm
47http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htmId.
48http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htmId.
49C.D. Lytle et al., A Sensitive Method for Evaluating Condoms as Virus Barriers, 80 J. AOAC Int.
319, 319-324 (1997); also Scientiﬁc Evidence on Condom Eﬀectiveness, supra note 25, at 7, available at
http://www.niaid.nih.gov/dmid/stds/condomreport.pdf.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
10as barriers to virus transmission notwithstanding a small chance of leakage.50 Leakage was typically on
the order of 0.1 microliter or less, or about 1/10,000 of a typical ejaculation which in such small amounts
would typically be virus-free in an HIV-infected person.51 Condoms that are intact, without major holes are
essentially impermeable to particles the same size as STD pathogens. These studies also show that ﬂuid ﬂow,
as opposed to virus size, is the most important determinant of viral transmission. Condoms with holes many
times larger than the virus impeded ﬂuid ﬂow to the extent that few of the test particles were transmitted.52
Of course, for many STDs such as those transmitted by skin-to-skin contact the risk of acquiring an infection
might not be proportional to the volume of ﬂuid passing through a permeable condom.
IV. Regulation
Condoms are regulated by the FDA as Class II medical devices.53 They were marketed and sold before the
Medical Device Amendments of 197654 were enacted and were therefore grandfathered into newly created
Class II as part of the initial classiﬁcation of all existing devices.55 The Amendments anticipated that the
FDA would establish mandatory performance standards for each Class II device, but such detailed regulation
proved unduly burdensome for the FDA and was never fully implemented.56 More recently, as part of the Safe
50C.D. Lytle et al., An in vitro evaluation of condoms as barriers to small virus in Sexually Transmitted Diseases, at
ch. 24, 161-164 (March 1997).
51McNeil, supra note 30, at ch.1, available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/pregandstdprev.htm;
See also R.F. Carey et al., Eﬀectiveness of latex condoms as a barrier to HIV-sized particles under conditions of simulated
use in Sexually Transmitted Diseases, at ch. 19, 230-234 (1992).
52A Sensitive Method for Evaluating Condoms as Virus Barriers, supra note 51, at 319-324.
53See Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, US House
of Representatives (March 11, 2004) (Statement of Daniel G. Shultz, Director, Oﬃce of Device Evaluation, Center for Devices
and Radiological Health, Food and Drug Administration), at http://www.fda.gov/ola/2004/condoms0311.html; see also 21
C.F.R. §§ 884.5300, 884.5310 (condoms with spermicidal lubricant).
54[Cite]
55See Statement of Daniel G. Shultz, supra note 55, at http://www.fda.gov/ola/2004/condoms0311.html.
56http://www.fda.gov/ola/2004/condoms0311.html Id.
11Medical Devices Act of 1990, Congress made Class II medical devices subject to FDA established optional
special controls, which are broader and less particular than mandatory performance standards. Thus far, the
FDA has not speciﬁed special control measures in connection with condoms.57 FDA regulation does extend,
however, to condom-makers marketing and selling condoms in the United States. Such regulations encompass
two regulatory regimes:58 pre-market controls which regulate condoms when they are ﬁrst introduced to the
market and post-market controls. The former regulatory structure relies upon 510(k) pre-market notiﬁcation
procedures59 while for the latter the FDA requires compliance with Quality System Regulation.
Pre-marketing notiﬁcation under Section 510(k)
The 1976 Amendments allow the FDA to control market introduction of all medical devices.60 One of the
three ways a new device may be legally marketed is when it is “substantially equivalent” to a device that
is already marketed.61 Speciﬁcally, every manufacturer or importer of a new medical device must provide
pre-market notiﬁcation (“PMN”) to the FDA under Section 510(k)62 with information to enable the agency
to determine whether the item is “substantially equivalent” to a legally marketed device that is already on
the market.63 Unless exempted from PMN requirements, a producer may not market a new device under
57Id.http://www.fda.gov/ola/2004/condoms0311.html
58Scientiﬁc Evidence on Condom Eﬀectiveness, supra note 25, at 6, available at
http://www.niaid.nih.gov/dmid/stds/condomreport.pdf.
5921 U.S.C. § 510(k) (2004); see also Scientiﬁc Evidence on Condom Eﬀectiveness, supra note 25, at 6, available at
http://www.niaid.nih.gov/dmid/stds/condomreport.pdf.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
60PB Hutt, at 745.
61“Substantially equivalent” is a deﬁned term that can be found in Section 513(i). 21 U.S.C. § 513(i).
62“Section 510(k) of the Act and the implementing regulation, 21 CFR Part 807, require persons who intend to market a new
device to submit a premarket notiﬁcation containing information that enables the FDA to determine whether the new device
is substantially equivalent within the meaning of Section 513(i) of the Act to a legally marketed device that does not require
premarket approval.” 21 U.S.C. § 510(k); 21 C.F.R. pt. 807.
63Scientiﬁc Evidence on Condom Eﬀectiveness, supra note 25, at 6, available at
12Section 510(k) without receiving a “substantial equivalent” order or an order classifying the device as a Class
I or Class II device.64
Male condoms, as noted previously, are Class II devices and are not exempt from 510(k) requirements, thus
510(k) PMN must be submitted to the FDA before a new male condom, or an existing condom that has
been substantially changed or modiﬁed, is introduced.65 Most new latex condoms meet the “substantially
equivalent” requirement with respect to condoms that were on the market before the 1976 Amendment.
Consequently, most new latex condoms are approved through the “substantially equivalent” requirements
contained in Section 513(i).
Oﬃce of Device Evaluation – Abbreviated 510(k) requirements
The FDA also allows abbreviated submissions for male condom PMN using consensus standards. Conforming
to recognized consensus standards reasonably assures the FDA of the safety and eﬀectiveness of several
aspects of medical devices, including male latex condoms. A 510(k) PMN that states that a device conforms
to recognized consensus standards will in most instances mean that the FDA will not need to review the
actual test data for those aspects of the product that the standards deal with. The FDA can still seek such
data if otherwise permitted by statute or regulation. Compliance with consensus standards may not always
http://www.niaid.nih.gov/dmid/stds/condomreport.pdf; see also Center for Devices and Radiological Health,
FDA, Latex Condoms for Men – Information for510(k) Premarket Notiﬁcations: Use of Consensus Standards for Abbreviated
Submissions, Guidence for Industry, July 23, 1998, available at http://www.fda.gov/cdrh/ode/ltxcondm.pdf (abbreviated
510(k) for male condoms) [hereinafter Latex Condoms for Men].
64See id.http://www.fda.gov/cdrh/ode/ltxcondm.pdf
65Id.http://www.fda.gov/cdrh/ode/ltxcondm.pdf
13be a suﬃcient basis for regulatory decisions. Speciﬁcally, if a new device or intended use raises safety and
eﬀectiveness concerns that are not addressed by a consensus standard, or if regulations are more rigorous
than consensus standards, compliance with consensus standards will not be adequate for marketing approval.
The FDA recognizes voluntary consensus standards for male latex condoms, as well as other standards, such
as the ISO 10993 standard for cytotoxicity, which is relevant to a 510(k) application for a latex condom.66
An annually updated list of approved consensus standards is posted on the FDA website.67 Manufacturers
can choose to make a declaration of conformity to any of the listed standards.68
The FDA-drafted guidance document for a PMN69 refers to the ASTM voluntary consensus standard for
condoms70 and the ISO voluntary consensus standard71 for biological evaluation of medical devices. The
guidance document serves as a structure for a producer to show compliance with these consensus standards
for male latex condoms. When the declaration of compliance with consensus standards is included in a
complete and accurate 510(k) PMN it can serve as the basis for an FDA ﬁnding of substantial equivalence.
ASTM and ISO voluntary standards for condoms
The FDA’s abbreviated guidance under a 510(k) PMN speciﬁcally requires the producer or importer to show
conformance with the ASTM Standard Speciﬁcation for Rubber Contraceptives (Condoms), D3492,72 and
66Id.
67See also Latex Condoms for Men, supra note 65, available at http://www.fda.gov/cdrh/ode/ltxcondm.pdf.http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm
68Id.; see also FDA Guidance on the Recognition and Use of Consensus Standards (Feb. 19, 1998)
69See also Latex Condoms for Men, supra note 65, available at http://www.fda.gov/cdrh/ode/ltxcondm.pdf.http://www.fda.gov/cdrh/ode/ltxcondm.pdf
70[Cite]
71[Cite]
72ASTM refers to the American Society for Testing and Materials, 100 Barr Harbor Drive, West Conshohocken, PA 19428.
ASTM’s website is http://www.astm.org.
14the ISO Standard 1099373 or Biologic Evaluation of Medical Devices.74 The ASTM standards are speciﬁc
for condoms, whereas the ISO standards apply to medical devices that are in contact with the body.
ASTM Condom standards deal with the physical properties of the condom, requiring that condoms are made
from natural rubber latex, are of certain dimensions and thickness,75 meet toxicity criteria, meet air burst
pressure and volume criteria and meet criteria for leakage and package integrity. Condoms must conform in
all respects to these requirements, unless variance is speciﬁcally noted. Where such a variance is disclosed,
the FDA requires separate disclosure that identiﬁes the variance from each standard and that explains how
the variation does not materially impact the condom’s “substantial equivalence.” Appendix 1 lists the ASTM
standards as well as other international condom standards.
The FDA standards are arguably inadequate given the technology that is available for condom testing. For
example, the ASTM standards only require visual leak testing, not electronic testing which is the standard
practice of condom producers.76 ASTM standards specify that the tester must ﬁll a sample of condoms from
each batch with water and look for water leaks using the naked eye.77 According to the FDA, the ASTM
water leak test, detects tiny holes in tested condoms, but does not assure that condoms are strong enough
to resist being broken during sex.78
73See A practical guide to ISO 10993: Part I – Introduction to the standards, Med. Device & Diagnostic Ind. Mag., Jan.
1998, available at http://www.devicelink.com/mddi/archive/98/01/023.html.
74See Id [27] at Page 9.
75With regard to condom dimensions, ASTM standards require condoms to have a minimum thinness of 0.3 mm and,
when laid-ﬂat, a maximum width of 54 mm and minimum length of 160 mm. McNeil, supra note 30, at ch. 5, available
at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm. It is noteworthy that the comparable
Japanese and European condom standards, as given by the ISO and CEO, do not specify a minimum condom thickness.
76Id. With regard to leakiness of condoms or detecting tiny holes, producers test every condom electronically too see if they
allow electricity through. Id.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm Rubber is an
electric insulator, so if current passes across a condom, that means there is a hole. Id.
77See idhttp://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm.
78See FDA, Office of Regulatory Affairs, 5 Compliance Policy Guide § 345.100, Male Condom Defects (March 29,
2002) (draft for comment), at www.fda.gov/ora/compliance ref/cpg/cpgdev/cpg345-100 draft.html [hereinafter Male Condom
Defects].
15To understand how well condoms can stretch and expand, ASTM standards also require an air burst test.79
The air burst tests required by the ASTM standard are destructive tests that blow condoms up like balloons.
During testing the pressure and volume of air that condoms are inﬂated with is increased until they burst.80
The air burst test thus measures the maximum strength of the weakest part of the entire condom.81 Research
indicates that the air burst test results correlate with how well condoms actually perform during sex.82
Conversely, when used during sex, condoms might not commonly burst at their weakest point, but rather at
their most stressed point, such as the closed end and tip of the condom. So there are proposals to have an
additional inﬂation testing component with higher performance standards for the closed end and tip of the
condom.83
Acceptable Quality Level
The tests do not require every condom in a sample to pass. Rather, each test, whether for size, leaks
or inﬂation, comes with an acceptable quality level (AQL) speciﬁcation.84 The AQL level and number of
allowable defects depends on the sample size tested.85 For example, using the ASTM leak test and applying
a 0.40 AQL would require gathering a random sample of 315 condoms from a batch of 150,000 to 500,000
79McNeil, supra note 30, at ch. 5, available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm
80See Male Condom Defects, supra note 80, at www.fda.gov/ora/compliance ref/cpg/cpgdev/cpg345-100 draft.html; see
also ISO 4074 and ASTM D3492 standards. Air burst tests have been adopted by many other countries, such
as Canada, Australia and the member countries of the European Union. Id. The ASTM standard requires con-
doms to be inﬂated to a minimum volume of sixteen liters and to a minimum pressure of one kiloPascal. See
http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htmMcNeil, supra note 30, at ch. 5, available
at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm.
81When a condom is inﬂated to bursting, it will typically break at its weakest part. McNeil, supra note 30, at ch. 5, available
at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm.
82M.J. Free et al., An assessment of burst strength distribution data for monitoring condom stocks
in developing countries, Contraception 1986; 33:285-99; see also McNeil, supra note 30, at ch. 5,
available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm, citing M.J.
Free et al., Relationship between condom strength and failure during use, Contraception 2980;22:31-37.
http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm
83McNeil, supra note 30, at ch. 5, available at http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm
84Id.
85Id.
16manufactured condoms. The batch passes the ASTM water leak test if no more than 3 condoms in the
sample have visible water leaks. If more than three condoms in the sample fail the test, then the entire
manufacturer batch of condoms is destroyed. If the AQL for the ASTM water leak test was tightened to
0.25, as has been proposed, this would require no more than two condoms to fail in the sample of 315.86
ISO Standards
The twelve part ISO standards generally aim to test and evaluate the eﬀects of medical device materials on
the body.87 In particular, four of the twelve ISO 10993 standards apply to male condoms.88 The ISO 10993
standards and the FDA ODE Bluebook Guidance memorandum #G95-189 demonstrate that the condom is
not cytotoxic,90 systemically toxic,91 sensitizing or locally irritating,92 or otherwise harmful.93 Unlike the
ASTM standards, the ISO standards describe test procedures and not performance thresholds or “passing
grades.”94 Therefore summaries of the testing results must be included with the PMN.95
Quality System Regulation of Condoms
The Quality System Regulation96 is a post-market regulatory control, which means that it applies to con-
doms that are already being sold on the market.97 The Regulation sets forth requirements to comply with
86Id.http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/standspectests.htm
87See Latex Condoms for Men, supra note 65, available at http://www.fda.gov/cdrh/ode/ltxcondm.pdf.http://www.fda.gov/cdrh/g951.html
88See http://www.fda.gov/cdrh/ode/ltxcondm.pdfid., at 9.
89FDA, Required Biocompatibility Training and Toxicology Proﬁles for Evaluation of Medical Devices, (G95-1) (May 1, 1995),
at http://www.fda.gov/cdrh/g951.html.
90ISO 10993-5 – Cytotoxicity.
91ISO 10993- 11 Systemic Toxicity.
92ISO 10993-10 – Irritation and Sensitization.
93cite
94Latex Condoms for Men, supra note 65, at 9, available at http://www.fda.gov/cdrh/ode/ltxcondm.pdf.http://www.fda.gov/cdrh/ode/ltxcondm.pdf. at page 9
95Id.
96See 21 C.F.R. pt. 820, available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=820&showFR=1.
97Scientiﬁc Evidence on Condom Eﬀectiveness, supra note 25, at 6, available at
http://www.niaid.nih.gov/dmid/stds/condomreport.pdf.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
17current desirable manufacturing practice.98 The Regulation requires condom manufacturers to adhere to
the following standards: (i) manufacturers must use quality assurance standards for new condom designs;
(ii) manufacturers must use valid processes in condom manufacture, so that they conform to their design
speciﬁcations; and (iii) manufacturers must apply strict product release criteria to condoms.99
Shipments and imports of condoms to the United States
When shipments of condoms contain defects or holes, they may be refused entry into the United States
under section 801(a)(3)100 because they appear to be of substandard quality.101 Essentially, these defective
condoms are considered adulterated pursuant to section 501(c).102 If these imported condoms are labeled
for the prevention of disease, then they are also considered misbranded under section 502(a), as the holes
and defects in the condoms make them ineﬀective at disease prevention.103
The FDA also holds imported condoms to similar quality standards.104 The FDA is permitted to seize
condoms that do not meet the ASTM D3492 water leak test105 and ISO 4074 and ASTM D3492 airburst
test speciﬁcations.106 Such condoms that do not provide an adequate barrier are considered adulterated.
Condoms that do not pass these tests satisfactorily may be considered adulterated and misbranded and may
be subject to direct reference seizure.107 The FDA lists sample charges that include the following:108
9821 C.F.R. § 820.1(a).
99Id.
100Id.
101Id.
102Cite
103See 502(a).
104See Male Condom Defects, supra note 80, at www.fda.gov/ora/compliance ref/cpg/cpgdev/cpg345-100 draft.html.
105Id. Speciﬁcally, if more than 0.25% (that is twenty-ﬁve out of ten thousand) condoms are leaky, then the batch fails the
test. Id. In 1987, when the ASTM standard was ﬁrst used by the FDA, the leakiness standard was just 0.4%. Id.
106Id.
107Id.
108See specimen charges at www.fda.gov/ora/compliance ref/cpg/cpgdev/cpg345-100 draft.html.
181.
For lots that FDA determines are adulterated on the basis of the water
leak test AQL or other factors, the FDA ﬁnds, [t]hat the article of device is adulterated
within the meaning of the Act, 21 U.S.C. 351(c), in that it is not subject to 21 U.S.C.
351(b) and its quality falls below that which it purports or is represented to possess in that
the devices contain defects/holes;
2. If the condoms contain holes and are labeled for the contraception, the FDA may ﬁnd a violation of 21
U.S.C. 351(c) and may also ﬁnd, [t]hat the article of device is misbranded within the meaning of the Act,
21 U.S.C. 352(a), in that its labeling [for the prevention of pregnancy] is false or misleading, because the
labeling fails to reveal a material fact in light of such representations, that the article contains holes;
3. If the seized lot was repacked by the dealer and it is believed that holes may have occurred during
repacking, the FDA may add a statement to the examination paragraph of the complaint ﬁnding, (Insert
name of ﬁrm) repacked the article of device from bulk stock after receipt in interstate commerce.109
Labeling
The FDA generally regulates condom labeling through medical device labeling requirements110 and uniform
contraceptive labeling requirements111 and more speciﬁcally through condom labeling regulations that require
condom expiration dating112 and warnings about allergies to rubber latex.113
As far back as 1987, the FDA has issued guidance related to condom labeling in connection with protection
against sexually transmitted disease.114 Condom packaging is typically labeled on an external box, which
109Cite
11021 C.F.R. pt. 801.
111FDA, Guidance for Industry, Uniform Contraceptive Labeling, July 23, 1998, at
http://www.fda.gov/cdrh/ode/contrlab.html.
11221 C.F.R. § 801.435.
113Id. § 801.437. The standard warning says: “Warning: This product contains natural rubber latex which may cause allergic
reactions.” See also Latex Condoms for Men, supra note 65, at 12, available at http://www.fda.gov/cdrh/ode/ltxcondm.pdf.
114See Statement of Daniel G. Shultz, supra note 55, at http://www.fda.gov/ola/2004/condoms0311.html.
19is called the “principal display panel.”115 The box must display the product’s “principal intended action.”
Condom packaging also contains more detailed information including user directions and other important
information, either on the box or on a package insert inside the box.116 FDA guidance suggests the “principal
intended action” include statements as to contraception and STD risk reduction. With respect to STD risk
reduction, recommended statements include the following:117
“Protection against sexually transmitted diseases (STDs).”
“If used properly, latex condoms will help to reduce the risk of transmission of HIV infection (AIDS)
and many other sexually transmitted diseases.”
“If used properly, latex condoms will help to reduce the risk of transmission of HIV infection (AIDS)
and many other sexually transmitted diseases, including chlamydia infections, genital herpes, genital
warts, gonorrhea, hepatitis B, and syphilis.”
Condoms with spermicidal lubricant must also carry special labeling, describing the contraceptive function
of the spermicidal lubricant nonoxynol-9. Such labeling must explain that the reduced risk of pregnancy has
not been quantiﬁed and that a condom coupled with spermicidal is not a substitute for a vaginal spermicide
and a condom.118
Condom package inserts must also include a contraceptive eﬀectiveness table with pregnancy rates for all
contraceptive methods.119 The FDA explains that requiring such a table will enable contraceptive users
to compare contraceptive alternatives and thereby make informed and educated choices. The FDA has
developed such a table for this purpose120 based on a leading textbook.121
Labeling must also incorporate suggested directions and precautions to follow including indications that
115See idhttp://www.fda.gov/ola/2004/condoms0311.html.
116See id.
117http://www.fda.gov/ola/2004/condoms0311.html See id.
118See also Latex Condoms for Men, supra note 65, at 12, available at http://www.fda.gov/cdrh/ode/ltxcondm.pdf.http://www.fda.gov/cdrh/ode/ltxcondm.pdf
119Id.http://www.fda.gov/cdrh/ode/ltxcondm.pdf
120FDA, Office of Women’s Health, Pregnancy Rates for Birth Control Devices (DATE).
121Contraceptive Technology (17th ed. Hatcher et al. YEAR). The table is available at
http://www.fda.gov/cdrh/ode/contrlab.html.
20condoms should be stored in a cool dry place, and also advice forewarning users not to reuse condoms, use
obviously damaged condoms or use oil-based lubricants which may damage condoms.122
V. Studies and Debates Fueling Condom Regulation and Social Policy
Activist groups often argue that the deterioration of America’s moral values is the result of government
sanctioning of “immoral” behavior such promoting condom use instead of abstinence. By promoting condoms,
such groups state, the government gives its citizens the impression that pre-marital sex or irresponsible sex
is acceptable and the proper way to protect against disease and pregnancy is to use protection rather than
practice abstinence. The American Social Hygiene Association, for instance, fought to ban condom use
in the early part of the twentieth century, particularly during World War I.123 The association felt that
negative consequences such as STDs and unwanted pregnancy that are inherent in non-marital sex and
promiscuity already served as deterrents to immoral behavior. Without this disease-based deterrence, it
argued, America’s morals would surely decline. During World War I, in a reﬂection of this ethos, American
armed forces were the only troops in Europe that were not provided condoms.124 This led to a 70% STD
infection rate, the highest of any ﬁghting force in Europe. Fundamentalist Secretary of the Navy Josephus
Daniels was one of many military leaders who believed condom use was immoral and “Un-Christian.”125
Pragmatics won over moral scruples, and by 1919 the US Army was spending a million dollars each year
on prevention of venereal disease, including distribution of condoms.126 The medical endorsement and wide
122See See also Latex Condoms for Men, supra note 65, at 13, available at
http://www.fda.gov/cdrh/ode/ltxcondm.pdf.http://www.fda.gov/cdrh/ode/ltxcondm.pdf
123Planned Parenthood Federation of America, Inc., A History of Contraceptive Methods citing Allan M. Brandt,
No magic bullet: a social history of venereal disease in the United States Since 1880 (Oxford Univ. Press. 1985), at
http://www.plannedparenthood.org/pp2/portal/ﬁles/portal/medicalinfo/birthcontrol/fact-020709-contraception-history.xml.
124See Brandt, supra note 125.
125See id.
126Linda Gordon, Women’s Body, Women’s Right: Birth Control in America 63-64 (Penguin Books USA 1990)
21distribution of condoms helped popularize them with the 4.8 million American men who served in World
War I.127
The moral debate again reared its head in the wake of the global AIDS epidemic. From 1987 the FDA
has issued various guidance documents on condom labeling related to STD protection.128 The FDA also
increased testing and quality standards for condoms.129 Through the FDA’s public outreach eﬀorts, it
has also promoted condom use, even to teenagers, as a way of protecting against STDs.130 For instance,
an FDA booklet promoting condoms, titled “Condoms and Sexually Transmitted Diseases ...Especially
AIDS,” states that “it’s important to use condoms (rubbers, prophylactics) to help reduce the spread of
sexually transmitted diseases.”131 The booklet qualiﬁes this recommendation by noting that abstinence and
monogamous intercourse with a non-infected monogamous partner are the only sure ways of avoiding STDs.
The booklet went on to note that condoms are not 100% safe in preventing STD infection. In another article
in its consumer magazine, the FDA quotes Herbert Peterson, M.D., chief of the Center for Disease Control’s
(“CDC”) women’s health and fertility branch, as saying that “[t]he scientiﬁc evidence [as to condom eﬃcacy
in preventing STD transmission] is compelling.”132
The government’s role in promoting condom use under the earlier rubric of “safe sex” and the later term
“safer sex,” generated social133 and political opposition134 from social conservatives. The opposition was not
127Id.
128See Statement of Daniel G. Shultz, supra note 55, at http://www.fda.gov/ola/2004/condoms0311.html.
129[Cite.]; also see, Consumer Reports, Feature Report: Condoms Get Better, June 1999, at
http://www.consumerreports.org/main/detail.jsp?CONTENT%3C%3Ecnt id=19263&FOLDER%3C%3Efolder id=18151.
130See e.g., FDA, On the teen scene: Preventing STDs , FDA Consumer Mag., June 1993, at
http://www.fda.gov/fdac/reprints/ots stds.html; see also Judith Levin Willis, US FDA, Latex Condoms Reduce the risk
of STDs, FDA Consumer Mag., September 1990, at http://www.fda.gov/bbs/topics/CONSUMER/CN00042c.html;
see also Tamar Nordenberg , Condoms: Barriers to Bad News, FDA Consumer Mag., March – April 1998, at
http://www.thebody.com/fda/condoms.html.
131See FDA, Condoms and Sexually Transmitted Diseases ...Especially AIDS, Brochure, at
http://www.fda.gov/oashi/aids/condom.html.
132See Nordenberg, supra note 132, at http://www.thebody.com/fda/condoms.html.
133For example, consider ‘The Pure Love Club,’ a Catholic chastity outreach program that can be found at
www.pureloveclub.com.
134See Heather Boonstra, Public Health Advocates Say Campaign to Disparage Condoms Threatens STD Prevention Eﬀorts,
22a new phenomenon, but rather was similar to the opposition to condom use (to stop venereal disease) before
and during World War I.135 The moral debate persists today where promotion and easy access to condoms
are feared as a “license to sexual immorality.”136 For social conservatives, easy access to a contraceptive
that is eﬀective, cheap, safe, prescription-free, anonymous “not only encourages but signals acceptance of
nonmarital, nonreproductive sex.”137
Condom opponents today cast their arguments in both scientiﬁc and moral terms.138 Morally, they have
argued that religion and tradition favored strict, reciprocal monogamy or abstinence. Scientiﬁcally, they
have publicly attacked the eﬃcacy of condoms in preventing STD infection,139 and called on the government
to limit or at least require condom promoters to teach abstinence in conjunction with safe sex marketing
campaigns.140 In addition, social conservatives have indirectly accused safer sex advocates of fraud for
in knowingly promoting condoms despite knowing of condoms’ ineﬃcacy for disease prevention. For in-
stance, conservative commentator Patrick J. Buchanan writes in The Great Condom Fraud and Cover-Up141
that “...[Secretary of State Colin] Powell’s testimonial to condoms as oﬀering protection against disease,
...appears to be one of the frauds of our time.”142 James Dobson, a prominent conservative and president
of Focus on the Family, noted that “[Powell] is talking about a subject he doesn’t understand. He clearly
doesn’t understand the science regarding condom eﬃcacy.”143 These comments were in response to former
The Guttmacher Report on Public Policy, March 2003, at 1, at http://www.guttmacher.org/pubs/tgr/06/1/gr060101.pdf.
135See id. at 477; Gordon, supra note 128, at 63-64, 309-310.
136Gordon, supra note 128, at 309-310.
137Linda Gordon, The Moral Property of Women: A History of Birth Control Politics in America 355 (Univ. of
Ill. Press 2002).
138The new government website for parents – www.4parents.gov – is designed for parents who are too shy to speak to their
children about sex. It clearly promotes the message that “abstinence is the healthiest choice.” It clearly illustrates that condoms
provide poor protection against many STDs and lists the high mean failure rates for various contraceptives. The site does not
have any advice on “safe sex.”
139See the table at http://www.4parents.gov/talktopics/table.htm.
140“Government spends $12 on Safe Sex and Contraceptives for Every $1 Spent on Abstinence: Heritage Foundation Back-
grounder #1718.” Melissa G. Pardue, Robert E. Rector, and Shannan Martin.
141See Patrick J. Buchanan, The American Cause, The Great Condom Fraud Cover-Up, March 1, 2002, at
www.theamericancause.org (search title in archives).
142See id.
143See BBC News, Powell’s condom comments draw ire, Feb. 16 2002, at
23Secretary of State Colin Powell’s remarks on MTV that “condoms are a way to prevent infection and there-
fore [he] not only support[s] their use [but he] encourage[s] their use among people who are sexually active
and need to protect themselves.”144
Catholic Church Discourages Condom Use to Fight AIDS in Third World
The Catholic Church has a long history of involvement in the controversy over whether promoting condoms
or abstinence is preferable to ﬁght the global AIDS epidemic, a problem especially severe in sub-Saharan
Africa and elsewhere in the Third World. Cardinal Alfonso Lopez Trujillo of Colombia, President of the
Vatican’s Pontiﬁcal Council on the Family, publicly remarked in 2003 that condoms don’t prevent AIDS
and may actually help spread the disease by creating a false sense of security.145 The Cardinal made these
remarks in a BBC Panorama program, “Sex and the Holy City.”146 Cardinal Lopez Trujillo defended these
extemporaneous remarks with a detailed twenty page statement (with eighty-four footnotes, including cita-
tions to multiple scientiﬁc sources) titled “Family Values versus Safer Sex.”147 In Cardinal Lopez Trujillo’s
words,
http://news.bbc.co.uk/1/hi/world/americas/1823739.stm.
144See id.
145See Nicole Winﬁeld, Associated Press, What is the Vatican Position on condoms to ﬁght AIDS?, March 20,
2004, at http://www.aegis.com/news/ap/2004/AP040334.html. In a more detailed statement, Cardinal Lopez Tru-
jillo says, “I am quite concerned because people, especially the young, are misled when total protection is seem-
ingly oﬀered to them, while in fact there is no such total protection.” See Cardinal Lopez Trujillo, Catholic
Culture, Family Values Versus Safe Sex, at http://www.catholicculture.org/docs/doc view.cfm?recnum=5836 (last vis-
ited May 23, 2005); See Interview by BBC on Vatican Radio with Cardinal Lopez Trujillo President of Pon-
tiﬁcal Council for the Family, Vatican City (Nov. 23, 2003) (eﬀectiveness of condoms to curb AIDS), at
http://www.catholic.org/featured/headline.php?ID=488http://www.catholic.org/featured/headline.php?ID=488.
146See Steve Bradshaw, The Guardian, Vatican: Condoms don’t stop AIDS, October 9, 2003, at
http://www.guardian.co.uk/aids/story/0,7369,1059068,00.html.
147Family Values Versus Safe Sex, supra note 147, at http://www.catholicculture.org/docs/doc view.cfm?recnum=5836.
24One cannot really speak of safe sex, leading people to believe that the use of condoms is
the formula to avoid the risk of HIV and thus to overcome the AIDS pandemic. Nor should
people be led to believe that condoms provide absolute safety. They do not mention that
there is a percentage of grave risk, not only of AIDS, but also of the diﬀerent sexually
transmitted diseases, and that the rate of failure is quite high.148
The Cardinal understands that the World Health Organization estimates that using condoms reduces 90%
of the risk of acquiring HIV and that it estimates that 99% of new HIV cases come from unprotected sex,
but his position claims that the residual risk is still unacceptably high for a mortal disease like AIDS.149 In
place of condoms, the Cardinal advocates “moral values of mutual ﬁdelity of spouses and chastity,”150 which
he says provide “absolute protection”151 in preventing disease. To discourage condom use (and presumably
promote chastity and ﬁdelity), the Cardinal recommends a mandatory warning notice on condom packaging,
similar to the warning on cigarettes that ﬁlters do not make the product safer, that states that condoms are
unsafe.152
Cardinal Lopez Trujillo’s written statement also oﬀers a detailed critique of safer sex, which he argues
promotes sexual promiscuity and condom use, which in his view are so ineﬀective as to be harmful.153 He cites
research showing that “HIV/AIDS cases increase as the number of condoms distributed also increases.”154
He also cites anecdotal reports that where abstinence and marital ﬁdelity has been promoted (Uganda for
example) the HIV/AIDS pandemic has “dramatically decreased”155 In Uganda, he cites a US Agency for
International Development (“USAID”) study that attributes falling HIV prevalence “more to reduction in
149Family Values Versus Safe Sex, supra note 147, at http://www.catholicculture.org/docs/doc view.cfm?recnum=5836.
http://www.catholicculture.org/docs/doc view.cfm?recnum=5836
150See Interview with Cardinal Lopez Trujillo, supra note 147, at http://www.catholic.org/featured/headline.php?ID=488.http://www.catholic.org/featured/headline.php?ID=488
151Family Values Versus Safe Sex, supra note 147, at http://www.catholicculture.org/docs/doc view.cfm?recnum=5836.http://www.catholicculture.org/docs/doc view.cfm?recnum=5836
152See Interview with Cardinal Lopez Trujillo, supra note 147, at http://www.catholic.org/featured/headline.php?ID=488.http://www.catholic.org/featured/headline.php?ID=488
153See id.http://www.catholic.org/featured/headline.php?ID=488
154See http://www.catholic.org/featured/headline.php?ID=488id. He references the graph showing an almost parallel
increase of condoms distributed by USAID and the spread of HIV/AIDS from 1984 - 2003, in the Population Research Institute
Review (May-Jun 2003), page 10, summarizing data from the Harvard School of Public Health, UNAIDS, and the Kaiser Family
Foundation. See id.
155See Family Values Versus Safe Sex, supra note 147, at http://www.catholicculture.org/docs/doc view.cfm?recnum=5836.
http://www.catholicculture.org/docs/doc view.cfm?recnum=5836
25sex partners than condoms.”156 As a result of condoms taking a back-seat to moral behavior, he notes that
Kampala has achieved an 80% HIV prevalence rate, which no other sub-Saharan country has matched.157
He also contrasts the much higher prevalence of HIV in Thailand than the Catholic Philippines, explaining
the diﬀerence by the Philippines’ low rates of condom promotion and staunch opposition from the Church
and government against promiscuity. In further support of his anti-condom views, Lopez Trujillo cites a
grouping of US doctors who accused the CDC of covering up its own research showing the ineﬀectiveness
of condoms to prevent the transmission of sexually transmitted diseases.”158 Also, Cardinal Lopez Trujillo
claimed that condoms have tiny holes through which the HIV virus can pass through.159
The Catholic Church has opposed condoms and contraception in general as it believes that every act of sex
should be open to conception.160 Contraception and condoms separate sex from procreation and signify
a society where life is not inherently valued. Thus, contraception and abortion are linked as pillars of a
“culture of death.” One of the doctors161 of the Catholic Church, St Augustine, condemned contraception
as against natural law saying, “[i]ntercourse even with one’s legitimate wife is unlawful and wicked where the
conception of the oﬀspring is prevented. Onan, the son of Juda, did this and the Lord killed him for it.”162
156See http://www.catholicculture.org/docs/doc view.cfm?recnum=5836id.
157USAID, Project Lessons Learned, Case Study, Sept. 2002, at 11 (Table: Simulation of Uganda HIV Dynamics: Potential
impact of similar behavior change in South Africa by 2000). On the same page, the Case Study report adds, “[i]t must be
remembered that many of the elements of Uganda’s response, such as high-level political support, decentralized planning, and
multi-sectoral responses, do not aﬀect HIV infection rates directly. Sexual behavior itself must change in order for seroincidence
to change. According to [the author of the study,] the eﬀect of HIV prevention interventions in Uganda (particularly partner
reduction) during the past decade appears to have had a similar impact as a potential medical vaccine of 80 percent eﬃcacy.”
Id.
158This is the same study that Rep. Coburn requested the CDC to conduct. See Interview with Cardinal Lopez Trujillo, supra
note 147, at http://www.catholic.org/featured/headline.php?ID=488.http://www.catholic.org/featured/headline.php?ID=488
159Cardinal Lopez Trujillo stated: “Two years later, the same reporter wrote in an article, 4 Popular Condoms Leak AIDS
Virus in Clinical Tests, that ‘[f]our of the nation’s most popular condom brands permitted the AIDS virus to escape in
laboratory tests conducted for UCLA, prompting researchers to warn users they should not assume that all condoms work
equally well in preventing spread of the disease....’ Overall, among the thousands of condoms tested, the study found that
0.66% of condoms—more than one of every 200—failed, either allowing water or air to escape, breaking in tensile strength tests
or leaking the AIDS virus.” Cardinal Lopez Trujillo, Article, Los Angeles Times, at ?? (Sept. 12, 1989).
160See Encyclical Humanae Vitae, Of Human Life.
161A doctor of the Catholic Church is a key contributor to its doctrine.
162Pius XI, Encyclical Letter No. 54, Casti Connubii, On Christian Marriage, at n. 45, citing St. August., De
coniug. adult., lib. II, n. 12, Gen, XXXVIII,at 8-10.
26Pope Pius XI also condemned contraception in his encyclical Casti Connubii (December 31, 1930) stating
that “the conjugal act is destined primarily by nature for the begetting of children, those who in exercising it
deliberately frustrate its natural power and purpose sin against nature and commit a deed which is shameful
and intrinsically vicious.”163
Notwithstanding these moral teachings against condoms and contraception, the Catholic Church permits a
limited “defense” of necessity, similar to the criminal law defense of necessity.164 Catholic Cardinal Godfried
Danneels of Belgium opined that if a person with HIV insisted on having sex, then he must use a condom,
or sin by risking transmission of a potentially fatal illness.165 Another Cardinal, Javier Lozano Barragan of
Mexico, stated that condom use was sometimes acceptable, as when a wife was forced to accept her HIV-
positive husband’s sexual advances.166 His rationale was that preserving life is paramount. As an illustration
of the complexities of a necessity defense, the Rev. Prof. Angel Rodriguez Luno, a moral theologian at the
Pontiﬁcal University of the Holy Cross in Rome, gave two examples.167 On one hand, she noted that a
Catholic priest cannot promote condoms in school, for this would be incitement of their use. But on the
other hand, she went on to ﬁnd that if the same priest was working as a social worker with prostitutes,
advising them to use condoms to avoid contracting AIDS, he is not encouraging an evil, but rather lessening
an evil that is already occurring. Rev. Prof. Rodriguez Luno acknowledges that a “lesser of two evils”
defense to condom use is supported by church documents going back 200 years.168
163Pius XI, supra note 164.
164Linked to the “necessity defense,” is the idea of the “lesser of two evils.” For example, according to Rev. Charles Curran,
a Catholic Professor of Human Values at Southern Methodist University, in the 1960s, the Vatican allowed nuns working
in the Congo who were at risk of rape to take contraceptive pills to prevent pregnancy. See Winﬁeld, supra note 147, at
http://www.aegis.com/news/ap/2004/AP040334.html.
165See http://www.aegis.com/news/ap/2004/AP040334.htmlid.
166See id.
167See id.
168See id.
27To little avail, local groups of Catholic Bishops have strived to formulate policy that balances a strong
condemnation of contraception against a need to defend against HIV. In 2001, despite soaring AIDS infec-
tion rates, the Southern African Catholic Bishops’ Conference condemned HIV-prevention programs that
encouraged condom use.169 The Conference stated the following:
[the Bishops] regard the widespread and indiscriminate promotion of condoms as an immoral
and misguided weapon in our battle against HIV/AIDS for the following reasons: [1] The use
of condoms goes against human dignity. [2] Condoms change the beautiful act of love into
a selﬁsh search for pleasure — while rejecting responsibility. [3] Condoms do not guarantee
protection against HIV/AIDS. [4] Condoms may even be one of the main reasons for the
spread of HIV/AIDS. Apart from the possibility of condoms being faulty or wrongly used
they contribute to the breaking down of self-control and mutual respect.170
The Conference would permit married couples where one partner is HIV-positive to use condoms if they
avoid sex while the woman is ovulating, so that condoms would not prevent the creation of life.171
Bishop Kevin Dowling of South Africa has urged the conference to be more tolerant of condom usage.172 In
an article in the US Catholic Magazine, he notes that there are thirty million people living with HIV in sub-
Saharan Africa, many of which are abused and vulnerable women.173 He suggests that the use of condoms,
not as contraception, but to prevent HIV infection deserves serious consideration.174 Such promotion, he
argues, does not go against traditional church teaching which is limited to the topic of contraceptive action.
Rather, the use of condoms to deal with AIDS is,
169See id.
171See A Message of Hope, supra note 172.
172Winﬁeld, supra note 147, at http://www.aegis.com/news/ap/2004/AP040334.html; See also US Catholic Mag., November
2003, at 20-25, available at http://www.uscatholic.org/2003/11/USCathHIV.pdf.
173Bishop Dowling opens his story with a heart-rending account of Lydia, a 22 year old prostitute dying of AIDS. US Catholic
Mag., supra note 174, at 21, available at http://www.uscatholic.org/2003/11/USCathHIV.pdf.
174See id.
28skin to the moral teaching that one can remove a diseased fallopian tube containing an
ectopic pregnancy since it was done for health reasons, thus allowing the secondary eﬀect
of abortion of the fetus. Or doctors can prescribe birth-control pills to stop dysfunctional
uterine bleeding or to correct irregular menstrual cycles.175
The Church, he says, citing the 1968 Papal Encyclical Humane Vitae,176 regards these actions as licit, even
though their eﬀect is the suppression of fertility.177 Thus, he argues, “[i]f one were to use [condoms] to
promote health – life rather than death – then one is not grudgingly accepting one evil to prevent a greater
one but rather one is promoting something that in the context is not simply good but a moral imperative.”178
Famously, Anglican Archbishop Desmond Tutu endorsed condom use on South African Television as a means
of combating the HIV/AIDS rate that is epidemic in sub-Saharan Africa.179 Tutu said that the Catholic
Church must be realistic in the matter of condom use, adding that it was irresponsible for the Church to
suggest that sex education and condom dissemination promoted promiscuity.180
The US Catholic Conference, an association of bishops, has criticized condom promotion as safer sex as far
back as 1987. It notes,
Abstinence outside of marriage and ﬁdelity within marriage as well as the avoidance of
intravenous drug abuse are the only morally correct and medically sure ways to prevent the
spread of AIDS. So-called safe sex practices are at best only partially eﬀective ...As the
National Academy of Sciences has noted in its study of AIDS, ‘many have argued that it is
more accurate to speak in terms of ‘safer’ sex because the unknowns are still such that it
would be irresponsible to certify any particular activity as absolutely safe.’181
176See id.
177Seehttp://www.uscatholic.org/2003/11/USCathHIV.pdf id.
178Winﬁeld, supra note 147, at http://www.aegis.com/news/ap/2004/AP040334.html;http://www.aegis.com/news/ap/2004/AP040334.html
See also US Catholic Mag., supra note 174, at 21, available at http://www.uscatholic.org/2003/11/USCathHIV.pdf.http://www.uscatholic.org/2003/11/USCathHIV.pdf
179McNeil, supra note 30, at ch.2, available at
http://www.fhi.org/en/RH/Pubs/booksReports/latexcondom/condomaccept.htm.
180Id.
29The issue of the legitimacy of condoms for AIDS prevention, as opposed to contraception, is still not settled.
The Vatican has not issued an encyclical, which is its most authoritative form of teaching and is held out
to the congregation as morally infallible, speciﬁcally about condoms and AIDS.182 Interviews with several
churchmen and theologians remarked that the issue was still being debated within the Vatican and is still
unresolved.183
Coburn’s Attempt to Put Warning Labels on Condoms
The “safe sex vs. abstinence” political battle has extended to the FDA’s regulation of condom labeling.
Social conservatives argue that condoms do not protect against STDs and that FDA-mandated condom
labeling should include warnings to this eﬀect. In 2000, in an eﬀort to require such labels, then-Rep Tom
Coburn184 (R-OK), a Catholic obstetrician and opponent of government-funded family planning programs,
tried unsuccessfully185 to amend Breast and Cervical Cancer Treatment Act186 to mandate labeling on
condoms that cautioned that condoms provide “little or no protection” against an extremely common STD,
human papillomavirus (HPV).187 In addition, condom labels would have to state that HPV was the cause of
cervical cancer.188 Also, federally funded sex education campaigns would have to issue similar warnings.189
Coburn pushed for the inclusion of the mandatory warning provisions in a bill that was primarily intended to
extend Medicaid coverage for breast and cervical cancer treatment for low-income women diagnosed under
a CDC-run early detection program.190 Coburn stated that the link between HPV and cervical cancer was
182Winﬁeld, supra note 147, at http://www.aegis.com/news/ap/2004/AP040334.htmlhttp://www.aegis.com/news/ap/2004/AP040334.html.
183See id.
184See Senator Tom Coburn, Homepage, at http://www.senate.gov/pagelayout/senators/one item and teasers/coburn.htm
(last visited May 24, 2005).
185Rep Coburn was successful in getting his warning on the House version of the bill, but not in its ﬁnal enacted form.
186The legislative history of the bill can be seen online at http://thomas.loc.gov/cgi-bin/query/z?c106:H.R.+4386.
187[Do some research and cite this]
188House approves labeling condoms with warnings about HPV infection. AIDS Policy and Law. May 26, 2000.
189House approves labeling condoms with warnings about HPV infection. AIDS Policy and Law. May 26, 2000.
190House approves labeling condoms with warnings about HPV infection. AIDS Policy and Law. May 26, 2000.
30as clear as the link between smoking and lung cancer, but less than one third of Americans are familiar
with the disease.191 He argued that Congress was obliged to “educate the American people about the risk
of contracting this dreaded virus,” adding that warning labels would “save lives and end the conspiracy of
silence surrounding HPV.”192 Speciﬁcally, he pushed to insert the following provision into the law:193
Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by inserting
after section 317G the following section: ...
(1) IN GENERAL.–The Secretary, acting through the Director of the Centers for Disease Control
and Prevention, shall– ...
(c) CONDOM EFFECTIVENESS; EDUCATION.–The Secretary shall require that the De-
partment of Health and Human Services and all contractors, grantees, and subgrantees of such
Department speciﬁcally state the eﬀectiveness or lack of eﬀectiveness of condoms in preventing the
transmission of HPV, herpes, and other sexually transmitted diseases in all informational materials
related to condoms or sexually transmitted diseases that are made available to the public. The
Secretary shall assure that such information is made available to relevant operating divisions and
oﬃces of the Department of Health and Human Services. This subsection shall be eﬀective within
6 months of the date of its enactment.”. ...
SEC. 4. LABELING OF CONDOMS WITH RESPECT TO HUMAN PAPILLO-
MAVIRUS.
(a) IN GENERAL.–Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is
amended by adding at the end the following: ...
(u) If it is a condom, unless its label and labeling bear information providing that condoms do
not eﬀectively prevent the transmission of the human papillomavirus and that such virus can cause
cervical cancer.
In May, the House voted 421-1 to pass the bill with these provisions included.194 The Senate, however,
removed the provision from its version of the bill and sent it back to the House in early October.195 Apart
from opposition within the Senate, there was also opposition from several medical groups, including the
American Cancer Society and the American College of Obstetricians and Gynecologists, as well as the
191House approves labeling condoms with warnings about HPV infection. AIDS Policy and Law. May 26, 2000.
192House approves labeling condoms with warnings about HPV infection. AIDS Policy and Law. May 26, 2000. Four types
of HP V are linked to 80% of cervical cancer deaths, which kills more than 4,500 US women each year. Current tests are costly
and error-prone, and annual Pap smear screenings are the best way of detecting the presence of precancerous cells. Condoms
may not work to prevent HPV as the virus is present on areas not covered by condoms, including stomach and groin skin.
Infections can spread from there to the cervix.
193House of Representatives, May 09, 2000. on page H2689.
194Condom-Labeling plan is deleted from cervical cancer bill, AIDS Policy and Law (Oct. 27, 2000) [hereinafter Condom-
Labeling plan is deleted], citing, AIDS Law and Policy 1 (May 26, 2000).
195Condom-Labeling plan is deleted, supra note 196.
31Clinton administration who feared the provision would discourage condom use.196 On October 12, 2000, the
House agreed to strip the provisions requiring condom warning labels from the bill.197
In the ﬁnal version of the law, PL 106-554 the “Breast and Cervical Cancer Treatment Act,” Coburn and his
allies in Congress inserted provisions requiring the Centers for Disease Control and the FDA to educate the
public about HPV.198 Part of the law also required that government-sponsored educational materials shall
“contain medically accurate information regarding the eﬀectiveness or lack of eﬀectiveness of condoms in
preventing the STD the materials are designed to address.”199 The CDC was given until December 21, 2003
to issue a report “including a detailed summary of the signiﬁcant ﬁndings and problems and best strategies
to prevent future infections, based on available science.”200
Coburn’s eﬀorts, according to Heather Boonstra of the Guttmacher Institute, were part of “a campaign to
disparage the value of condom use ...the cornerstone of an eﬀort to undermine the very notion of sexual
risk-reduction, or ‘safer sex.”’201 Experts in HIV and STD prevention were concerned that the conservative
eﬀort to promote chastity by cautioning the public as to condoms’ inadequacies would backﬁre.202 Decreased
public conﬁdence in condoms might lead to decreased condom use, which would lead to increased STD and
HIV infection rates if sexual behavior was otherwise unaﬀected. Of course, if abstinence advocates were
correct and frightening the public into accepting the alleged inadequacy of the condom to assure “safer sex”
led to more abstinence and monogamy, then STD and HIV infection rates might fall. Disease prevention
experts nevertheless maintain that a “conclusion that correct condom use does not oﬀer a high degree of
196Id.
197Id..
198[Cite]; see Boonstra, supra note 136, at 1, at http://www.guttmacher.org/pubs/tgr/06/1/gr060101.pdf.
199See Boonstra, supra note 136, at 1, at http://www.guttmacher.org/pubs/tgr/06/1/gr060101.pdf.
200See id.
201See id.
202See id.
32protection against the vast majority of STDs, not to mention HIV and unintended pregnancy, is simply not
warranted by the science....”203 In addition, these experts say that condom critics are “selectively citing
and intentionally misrepresenting” ﬁndings from the National Institute of Health (“NIH”) workshop report
to support their case.204
June 2000: NIH Workshop Conducted by the FDA, NIH, USAID, and CDC
As required by federal law,205 in June 2000 the National Institute of Allergy and Infectious Diseases, part
of the NIH, convened a workshop entitled “Scientiﬁc Evidence on Condom Eﬀectiveness for Sexually Trans-
mitted Disease Prevention.”206 The workshop was tasked with answering the following speciﬁc question:
“What is the scientiﬁc evidence on the eﬀectiveness of latex male condom-use to prevent STD transmission
during vaginal intercourse?”207 Over 180 persons attended the workshop including twenty-eight experts208
who subsequently wrote the report that was presented to Congress. The report examined the published
peer-reviewed scientiﬁc data209 on the eﬀectiveness of condoms in preventing eight speciﬁc STDs:210 HIV,
gonorrhea, Chlamydia, syphilis, chancroid, trichomoniasis, genital herpes, and human papillomavirus.211
The meeting and report, however, only discussed the scientiﬁc literature and were explicitly “not intended
to make public health policy recommendations regarding the role of condoms in HIV and STD prevention
policy and program.212
203See id.
204See http://www.guttmacher.org/pubs/tgr/06/1/gr060101.pdfid.
205See id.
206Scientiﬁc Evidence on Condom Eﬀectiveness, supra note 25, available at http://www.niaid.nih.gov/dmid/stds/condomreport.pdf.
207Id. at i.
208See id. at i Appendix Ahttp://www.niaid.nih.gov/dmid/stds/condomreport.pdf.
209Id. One hundred thirty-eight peer-reviewed scientiﬁc articles published before June 2000 were compiled
and reviewed, and were cited in the report’s bibliography. See id. at ii Appendix B, Bibliography, 1-
14.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
210Id. at i.
211Id.
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33The report starts by noting that STDs are “common, important and preventable” diseases in the United
States with considerable social impact, including death, illness, infertility, adverse pregnancy outcomes213
and lost work and health care costs. Over 65 million people in the US are living with an STD, most of
which are incurable viral infections and over 15 million new infections occurs each year.214 Over 493,000
individuals have died from AIDS, and over 800,000 people are living with HIV.215 In particular, and in
reference to the congressional inquiry and proposed condom safety warning,216 the report notes that HPV
can cause cervical and anogenital cancer.217 The report then notes that in the absence of STD vaccines and
eﬀective microbicides218 there are only three ways for reducing the risk of STD acquisition: (i) not having
sex, (ii) lifelong monogamy among uninfected couples, and (iii) using condoms.
In discussing the condom literature, the report distinguishes between condom eﬃcacy and eﬀectiveness.219
Eﬃcacy refers to the protection that “users received under ideal circumstances” that is when condoms are
used “correctly and consistently,” while eﬀectiveness refers to the protection users receive under actual or
typical conditions of use.220 Eﬃcacy primarily depends on the characteristics and properties of the condom,
whereas eﬀectiveness also depends on user behavior and attributes.221 A key issue in interpreting research
and in determining whether it is prudent to promote or discourage condom use is disentangling these two
measures of protection. Thus, a key source of condom failure to prevent disease transmission might be
incorrect or inconsistent use, such as failing to use a condom for each act of sex from start to ﬁnish. If
this is the case, the increased funding for condom promotion and safer sex education, rather than attacking
213Id. (including miscarriage, entopic pregnancy, stillbirth, intrauterine growth retarded and transmission of illness to the
baby).http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
214http://www.niaid.nih.gov/dmid/stds/condomreport.pdfId.
215Id.
216Note that in the House version of the bill, then-Rep. Coburn has proposed a warning that 1) condoms don’t prevent HPV
transmission, and 2) HPV leads to cancer of the cervix.
217http://www.niaid.nih.gov/dmid/stds/condomreport.pdfId.
218Id.
219Id. at 3.
220http://www.niaid.nih.gov/dmid/stds/condomreport.pdfId.
221Id. at 4.
34condoms, could help reduce STD transmission. On the other hand, denigrating condom eﬀectiveness might
lead to inconsistent or no use which would reduce the net eﬀect on STD prevention.
The best method to assess protection is through a prospective randomized controlled clinical trial, however,
such a method cannot be employed due to the ethical issues involved with exposing people to a high risk of
STD acquisition.222 The published studies are a poor substitute. The studies that the expert panel were able
to review were fraught with various of ﬂaws, including the following: (i) looking to clinical manifestations
of disease, rather than precise diagnostic tests; (ii) insuﬃcient subjects to assure statistical accuracy; (iii)
study populations, such as commercial sex workers, were not representative of the general population; (iv)
gender diﬀerences were ignored in the studies; (v) methods to detect infection were poor; (vi) failure to elicit
full information on condom use behavior and sexual history; (vii) imprecise quantiﬁcation of condom use,
including breakage and slippage events; and (viii) inability to document exposure to disease during condom
use.223
The panel found that the data most strongly supported the eﬀectiveness of condoms in preventing HIV
infection.224 The data225 show that among couples226 who report always using condoms, there is are 0.9
infections per one hundred persons per year, whereas among those couples that do not use condoms, there
are 6.7 infections per one hundred persons per year.227 Thus, always using condoms (a component of
complete and consistent condom use) reduces the risk of HIV transmission by 85%. There was also strong
data available for gonorrhea, with various studies supporting a 40-75% relative reduction in risk of a man
222Id. at 5-6.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
223Id.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
224Id. at i, 13.
225Id. at 14.; See also note 28 on page 3 of Appendix B, listing, Davis KR and Weller SC. The Eﬀectiveness of Condoms in
Reducing Heterosexual Transmission of HIV. Fam Plann Perspect. 1999; 31(6): 272-279.
226Couples where one has HIV and the other does not.
227Scientiﬁc Evidence on Condom Eﬀectiveness, supra note 25, at 15, available at
http://www.niaid.nih.gov/dmid/stds/condomreport.pdf.
35acquiring gonorrhea from an infected woman.228 Only one study speciﬁcally looked at the protective eﬀect
of condoms against the transmission of Chlamydia to men, which found a 0% (0/72) infection rate in men
consistently using a condom, as compared with a 6.3% (16/251) infection rate in men who did not always
use a condom.229 Taken as a whole, the studies concerning Chlamydia infections do “not allow an accurate
assessment of the degree of potential protection against [infection] oﬀered by correct and consistent condom
use.”230 With regard to trichomoniasis, one limited study showed a 30% protective eﬀect for women, but as
with chlamydia, the data does not allow an accurate assessment of risk reduction associated with condom
use.231
Genital ulcerative diseases examined included genital herpes, syphilis, and chancroid, where infectious agents
are present in sores or ulcers, as well as in human secretions.232 The studies show that condoms may work
to reduce the risk of disease transmission if they fully cover the site where sores and ulcers are present. With
regard to genital herpes, the most common ulcerative disease, ﬁve studies233 showed some reduction in risk
with condom use.234 Limitations in the design of these studies, however, and a lack of “primary outcome
measurements” meant that no conclusions could be drawn as to the eﬀectiveness of condoms to prevent the
transmission of genital herpes when correctly and consistently used.235 Chancroid is a very rare disease in
the US, with just 1000 cases each year. Only two studies were relevant to assessing prevention rates, but
niether included microbiological conﬁrmation of the disease, therefore conclusions as to condom eﬀectiveness
could not be drawn.236 With regard to syphilis, another rare disease,237 various studies showed condom
228Id. http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
229Id. at 17.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
230Id.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
231Id. at 18.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
232Id.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
233Id.
234Id.
235Id. at 20.
236Id. at 21.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
237Id. (a rate of 2.2 / 100,000). http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
36eﬀectiveness, but poor study design prevented the panel from properly assessing the degree of risk reduction
aﬀorded by correct and consistent condom use.238
HPV infection, singled out initially in the bill that Rep Coburn proposed,239 could not be neatly categorized
in the ulcerative or discharge STD dichotomy that the panel used to classify other STDs.240 Currently,
about twenty million adults in the United States are infected with genital HPV, while more than 50% of
sexually active adults have been infected in the past.241 “Signiﬁcant majorities” of these infections are
“asymptomatic, unrecognized and benign.”242 Types of genital HPV infections, denoted as high-risk, are
associated with cancer of the cervix, as well as anal and genital cancer and pre-cancerous tissue changes of
the cervix. Other types are not associated with cancer, but cause genital warts and ﬂat lesions on the cervix
and low-grade Pap smear abnormalities.243 HPV infections occur inside the genitals and also infect the skin
surrounding the genitals and may be transmitted by the hands and nails of an infected person.244 Thus,
while transmitted by sexual contact, HPV can be also be transmitted by areas not covered or protected by
the condom, suggesting that condoms at best only partly reduce the risk of disease transmission.245
Of the twenty-four papers the panel initially considered, it found the sixteen were suﬃcient for further
discussion in its report.246 None of the four studies which examined condom use as a factor in reducing the
238Id. at 23.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
239Id.
240Id. (“Genital HPV infection cannot be classiﬁed exclusively as an STD which is transmitted by gential secretions or which
is transmitted through contact with open sores. HPV is probably transmitted through contact with infected epithelial surfaces
and/or genital ﬂuids containing infective viruses.”). http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
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Panel, Estimates of the incidence and prevalence of sexually transmitted disease in the United States in Sexually Transmit-
ted Diseases, at ch. 26, 52-57 (suppl. 1999).
242N.B. Kiviat et al., Cervical neoplasia and other STD-related genital tract neoplasias in Sexually Transmitted Diseases,
at ch. 59 (3rd ed. Holmes et al., eds., McGraw-Hill 1999).
243Scientiﬁc Evidence on Condom Eﬀectiveness, supra note 25, at 24, available at
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37risk of HPV transmission found any risk reduction.247 In speciﬁcally analyzing genital warts, a subtype of
HPV infections, two retrospective studies found that condoms gave some risk reduction of 30% and 52%
for warts in men.248 In women, one study examining the protective eﬀect of condoms showed a 30% risk
reduction in acquiring genital warts, but this was not statistically signiﬁcant. Ten studies in women measured
the risk reduction in acquiring dysphasia and cancer of the cervix with the following results: (i) six showed
condom users having a statistically signiﬁcant reduction in risk, (ii) two did not show statistically signiﬁcant
risk reductions, and (ii) two showed no evidence of even partial protection.249
In reviewing these studies, the panel reported diﬃculties in achieving the congressionally mandated “coherent
and actionable interpretation.”250 Studies diﬀered not only in their methodology and measured outcomes,
but also in results for those with similar objectives.251 In addition, most of the studies did not track condom
use carefully.252 Retrospective studies suﬀered from uncertainties as to how accurately subjects reported
their condom use behavior for several years back. The panel concluded that “there was no evidence that
condom use reduced the risk of HPV infection, but study results did suggest that condom use might aﬀord
some reduction in risk of HPV-associated diseases, including genital warts in men and cervical dysphasia in
women.”253
The panel concluded by asking for more research, noting the need for “better-designed studies to assess
condom eﬀectiveness for STD prevention,”254 despite the diﬃculties in designing a study that is both sci-
entiﬁcally valid and ethically sound.255 The panel found that their ability to draw conclusions as to the
247Id. at 25.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
248Id.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
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252Id.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
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255Id. Ethical considerations discussed by the panel included: 1) Timely diagnosis and treatment of research subjects with
curable STDs, and provision of the best available preventive services, including condoms and condom counseling, to couples
38protective eﬀect of condoms was, at best,
signiﬁcantly hampered by the lack of adequate study design in most, but not all studies
under review. Exceptions to this generalization are the studies that demonstrated that the
consistent use of male condoms protects against HIV/AIDS transmissions between women
and men. Gonorrhea transmission to men was also found to be reduced with consistent and
correct condom use. Better research is necessary to adequately answer the question about
condom eﬀectiveness in reducing the risk of acquiring other STDs.256
Of course, the panel noted that “inadequacies of the evidence available ...should not be interpreted as proof
of the adequacy or inadequacy of the condom.”257
Responses to the NIH Studies
On July 19, 2001,258 Coburn issued a press release, “Safe Sex Myth Exposed by Scientiﬁc Report; Condoms
Do Not Prevent Most STDs.”259 His report commended the NIH report for “ﬁnally exposing the ‘safe’ sex
myth for the lie that it is.”260 While no longer a Congressman, Coburn was now Co-chair of the Presidential
Advisory Council of HIV/AIDS,261 and advocated that “the American people should know the truth of
condom ineﬀectiveness.”262 He argues that the only way to achieve safe sex is to continue promoting policies
favoring abstinence.263 In an interview he gave to the Advocate, Coburn said he believed in condoms to
prevent HIV infection, but he qualiﬁed this belief reiterating his belief in “informed consent about the
where one member has an incurable STD; 2) All subjects must be told of and given access to the “best available preventive
measures”; 3) As the consistent use of condoms has been shown to reduce the risk of acquiring some STDs, research subjects
cannot ethically be randomized into condom use and non-use groups; denying persons at risk of STDs from an eﬀective preventive
device is tantamount to withholding available treatment. Id. at 27.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
257Id. at ii.http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
258See Jan LaRue, Esq., Concerned Woman for America, Porn Industry Plauged by HIV and DOJ, Apr. 29, 2004, at
http://www.cwfa.org/printerfriendly.asp?id=5585&department=legal&categoryid=pornography.
259Id.
260See Boonstra, supra note 136, at 2, at http://www.guttmacher.org/pubs/tgr/06/1/gr060101.pdf.http://www.guttmacher.org/pubs/tgr/06/1/gr060101.pdf
261See Louis W. Sullivan, M.D. & Thomas A. Coburn, M.D., Presedential Advisory Counsel on HIV/AIDS, Letter, May
1, 2002, at http://www.pacha.gov/actions/correspondence/pres/corr pres5 02/corr pres5 02.html.
262Id.
263Id.
39eﬀectiveness of condoms” stating, “[a]sk any expert you want, and they will tell you that condoms are not
always eﬀective, and people have a right to know this.”264
Another pro-abstinence group, the Medical Institute for Sexual Health, summarized and analyzed the NIH
report. It concluded that condoms are so inherently unreliable that the government should not promote their
use for STD prevention.265 Rather, the government should advance marriage and abstinence as lifestyles that
eﬀectively prevent STDs.266 A consortium of groups, speciﬁcally the Physicans’ Consortium, accused the
CDC for concealing research on condom ineﬀectiveness.267 The Consortium, with nearly 10,000 physicians
represented, stated that the CDC has “systematically hidden and misrepresented vital medical information
regarding the ineﬀectiveness of condoms to prevent the transmission of STDs.”268 Further, “[t]he CDC’s
refusal to acknowledge clinical research has contributed to the massive STD epidemic.”269
Attacks on condom eﬃcacy have reached at least some people resulting in a decrease in condom use during
risky sex. According to Bill Smith, Director of Public Policy for the Sexuality Information and Education
Council of the United States (SIECUS),
Time and time again, we learn in focus groups with young people that they are being
taught that condoms don’t work, that HIV can get through holes in them. So they don’t
even bother using them. While it is true that condoms are not eﬀective 100% of the time,
we know for a fact that they are eﬀective against the transmission of HIV.270
The CDC initially responded to the attack on condom eﬃcacy by withdrawing a fact sheet on condom
264Bush’s abstinence man: Tom Coburn, head of the president’s AIDS advisory council, preaches
his preference for just say no over condom-based HIV education, The Advocate, May 28, 2002, at
http://www.ﬁndarticles.com/p/articles/mi m1589/is 2002 May 28/ai 86128322 [hereinafter Bush’s abstinence man: Tom
Coburn].
265Id.
266See Boonstra, supra note 136, at 1, at http://www.guttmacher.org/pubs/tgr/06/1/gr060101.pdf.http://www.guttmacher.org/pubs/tgr/06/1/gr060101.pdf
267See Pure Love Club, Chastity Q & A, at http://www.pureloveclub.com/chastity/index.php?id=7&entryid=284 (last
visited May 24, 2005)
268See id.
269See id.http://www.pureloveclub.com/chastity/index.php?id=7&entryid=284
40eﬀectiveness271 from its public website in October 2002.272 A group of House Democrats, led by Henry
Waxman, on October 21, 2003, wrote to the then Secretary of Health and Human Services explaining that
he was concerned that “scientiﬁc information that doesn’t ﬁt the Administration’s political agenda is being
suppressed.”273 In addition to removing the information about condoms, the National Cancer Institute had
also removed a page on its site denying any link between breast cancer and abortion, as well as a CDC page
that included advice on helping at-risk children avoid HIV and STD infection.274
Condom opponents continued to gear-up attacks on condom use, trying to get HPV warning labeling on
condoms. On February 12, 2004, Indiana Representative Souder, Chairman of the Subcommittee on Crim-
inal Justice, Drug Policy and Human Resources, wrote to FDA Commissioner Mark McClellan to express
his concern regarding condom labeling.275 The letter asked the Commissioner to look into revising what
he called inaccurate condom labeling as to HPV prevention in light of the CDC Report. Rep Souder cited
recent research, including a meta-analysis of research studies published in the journal Sexually Transmit-
ted Diseases276 that showed no consistent evidence of the protective eﬀect of condom use on HPV DNA
detection.277 Souder also noted that some studies examined actually indicated a slightly increased risk of
lesions.278 Rep Souder demanded action stating the following:
271A comparison of the two versions of the CDC website in connection with condoms can be viewed online. The original
website: CDC, Condoms and Their Use in Preventing HIV Infection and Other STDS (Sept. 1999) is available on-line at
www.house.gov/reform/min/pdfs/pdf inves/pdf admin hhs info condoms fact sheet orig.pdf.
For the current sheet, see CDC, Fact Sheet for Public Health Personnel: Male Latex Condoms and Sexually Transmitted
Diseases, available at http://www.cdc.gov/hiv/pubs/facts/condoms.htm (Updated Jan. 23, 2003).
272See CBS News, Critics: Feds Hiding Health Data, Nov. 26, 2002, at
http://www.cbsnews.com/stories/2002/11/26/politics/main530888.shtml; see also, Adam Clymer, U.S. Revises Sex In-
formation, and a Fight Goes On, The New York Times, Dec. 27, 2002.
273See AUTHOR, Drug Discovery and Development, “science Pulled in Political Struggle”, at
http://www.dddmag.com/ShowPR.aspx?PUBCODE=016&ACCT=1600000100&ISSUE=0409&RELTYPE=PR&ORIGRELTYPE=PNP&PRODCODE=00000000&PRODLETT=O
(last visited on May 24, 2005).
274See CBS News, supra note 274, at http://www.cbsnews.com/stories/2002/11/26/politics/main530888.shtml.
275See Pure Love Club, supra note 269, at http://www.pureloveclub.com/chastity/index.php?id=7&entryid=284.
276[Cite] in November 29, 2002 edition.
277Id.
278Id.
41Three years after Public Law 106-554 was signed by President Clinton, condom labels still do
not warn consumers about the lack of protection against HPV infection. The Subcommittee
urges FDA to act on the release of CDC’s HPV prevention report and immediately re-label
condoms to alert consumers that condoms do not provide eﬀective protection against HPV
infection.279
At about this time, in February 2004, the Union of Concerned Scientists released a statement titled “Restoring
Scientiﬁc Integrity in Policymaking,” arguing that when science conﬂicts with political expediency, the
administration has “often manipulated the process through which science enters into its decisions.”280 The
Union included allegations of suppression and censorship of the government’s own scientist.281 Distinguished
scientists including forty-eight Nobel laureates, and 127 members of the National Academy of Sciences signed
the statement.282 The Union noted in an accompanying special report that factual information on the
CDC website has been “altered to raise scientiﬁcally questionable doubts about the eﬃcacy of condoms
in preventing the spread of HIV/AIDS.”283 It noted that the earlier CDC fact sheet had been rewritten
in October 2002 to highlight condom failure rates and the eﬀectiveness of abstinence and monogamy.284
Relying on an interview with a conﬁdential source within the CDC, the Union’s report noted that the
changes were directed by Bush political appointees at the Department of Health and Human Services.285
The Union followed this up with a later general ﬁnding in June 2004 that “the Bush administration continues
to suppress and distort scientiﬁc knowledge and undermine scientiﬁc advisory panels.”286
The CDC later introduced a revised version of the condom fact-sheet, adding in bold letters (the only
bolded text on the page) that “[t]he surest way to avoid [...] [STDs] is to abstain from sexual
280Union of Concerned Scientists, Restoring Scientiﬁc Integrity in Policymaking, Statement (Feb. 18, 2004), at
http://www.ucsusa.org/global environment/rsi/page.cfm?pageID=1320.
281http://www.ucsusa.org/global environment/rsi/page.cfm?pageID=1320Id.
282Id.
283See Union of Concerned Scientists, Scientiﬁc Integrity in Policymaking: An Investigation into the Bush Administra-
tion’s Misuse of Science, at 12 (March 2004), available at http://www.ucsusa.org/rsi.
284Id.http://www.ucsusa.org/rsi
285See id. http://www.ucsusa.org/rsi
286See Union of Concerned Scientists, New Cases of Scientiﬁc Abuse by Administration Emerge, Press Release (July 8,
2004), at http://www.ucsusa.org/news/press release.cfm?newsID=405.
42intercourse, or to be in a long-term mutually monogamous relationship with a partner who has
been tested and you know is uninfected.”287 While it notes that correct and consistent condom use can
protect against STDs, the fact sheet emphasizes that condom use cannot guarantee absolute protection.288
The site also includes a suggested boxed notice about the protective eﬀect of condoms, perhaps as a summary
for clinicians or to substitute for the current FDA-required condom labeling.289 It reads,
Sexually transmitted diseases, including HIV
Latex condoms, when used consistently and correctly, are highly eﬀective in preventing
transmission of HIV, the virus that causes AIDS. In addition, correct and consistent use of
latex condoms can reduce the risk of other sexually transmitted diseases (STDs), including
discharge and genital ulcer diseases. While the eﬀect of condoms in preventing human
papillomavirus (HPV) infection is unknown, condom use has been associated with a lower
rate of cervical cancer, an HPV-associated disease.290
VI. The Current Debate:
Hyping Condom Ineﬀectiveness to Strengthen Pro-Abstinence Policies291
The current political climate is ripe to facilitate the “safe sex vs. abstinence” debate. The Bush administra-
tion strongly promotes abstinence outside marriage assuring pressure on the FDA to revise its pro-condom
policies. On March 25, 2005, the Department of Health and Human Services, led by former Utah Gov-
ernor Michael O. Leavitt,292 joined the debate with a controversial pro-abstinence website for parents,
www.4parents.gov.293 Secretary Leavitt points out that “[p]arents have a tremendous amount of inﬂuence
287See Fact Sheet for Public Health Personnel, supra note 273, available at http://www.cdc.gov/hiv/pubs/facts/condoms.htm.
288Id.
289Id.
291Phrasing derived from Chris C. Mooney’s web blog, entry dated Nov. 3, 2004, More on Tom Coburn’s Campaign Against
Condoms, at http://www.chriscmooney.com/blog.asp?Id=1332.
292“Michael O. Leavitt was sworn in as the 20th Secretary of the U.S. Department of Health and Human Ser-
vices on January 26, 2005.” U.S. Dept. of Health and Human Services, Biography of Mike Leavitt, at
http://www.hhs.gov/about/bios/dhhssec.html (last revised Jan. 26, 2005).
293See Department of Health and Human Services, HHS Announces New Communication Tools to Help Parents Talk to
Their Teens About Abstinence, Press Release, March 25, 2005, at http://www.hhs.gov/news/press/2005pres/20050325.html.
43on their children and we (speaking on behalf of society in general) want them to talk with their teens about
abstinence so that they can stay safe and healthy.”294 The site prominently warns against the dangers of
sex noting deleterious results of extra-marital sexual activity including poverty, crime, pregnancy and STDs
all despite condom use.295 It argues that condoms are too unreliable to protect our teenagers from these
socially undesirable consequences.296 Thus, it advises parents: “What do you tell your teen? Be ﬁrm in
your decision to delay sex.”297
The site emphasizes abstinence and chastity over condom use, which it denigrates as being ineﬀective.298 The
site also includes a table included from a government website that states that condoms are largely ineﬀective,
not even 50% eﬀective, in preventing most STDs, with the exceptions of HIV/AIDS, where condoms are
noted as having an 85% eﬀective rate.299 The table is included herein as Appendix 2.
The controversial website was greeted on March 31, 2005, with written condemnation from 145 public health
and advocacy groups.300 Monica Rodriguez, vice president for education and training of SIECUS, remarked
that “[u]nfortunately, 4parents.gov is not about educating parents, it is about scaring them. This Web site
relies on fear to motivate and contains misinformation and biases that undermine its intent of encouraging
parent-child communication around sex and sexuality.”301
President Bush (together with his administration) has been a strong advocate for abstinence-only sex ed-
294See id.http://www.hhs.gov/news/press/2005pres/20050325.html
295See id.
296See id.
297See http://www.4parents.gov/facts/index.htm.
298See http://www.4parents.gov/facts/index.htm.
299
300US Newswire, 145 Public Health and Advocacy Organizations Seek Removal of 4Parents.gov, a New HHS Web Site;
Web Site Includes Medical Inaccuracies, Biases, Fear-Based Messages, Groups Say, (last visited March 31, 2005); at
http://releases.usnewswire.com/GetRelease.asp?id=45145.
301Id.http://releases.usnewswire.com/GetRelease.asp?id=45145
44ucation.302 White House spokesman Ari Fleischer has stated that “abstinence is more than sound science,
it’s a sound practice. ...[A]bstinence has a proven track record of working.”303 According to a 2003 House
Minority Committee on Government Reform Report entitled “Politics and Science in the Bush Adminis-
tration,” the administration is distorting scientiﬁc evidence in claiming that abstinence-only sex education
is scientiﬁcally proven as eﬀective.”304 The Committee further argues that rather than relying on solid
science, the administration has “changed [the] performance measure for abstinence-only education to make
the programs appear successful, censored information on eﬀective sex education programs, and appointed to
a key panel an abstinence-only proponent with dubious credentials.”305 For instance, rather than tracking
pregnancy, STD infection or sexual activity as outcomes, measures adopted by the Bush administration track
the attendance, attitudes and “understanding” of participating youths.306 The fallacy of such measurements
is that beliefs, attitudes and intentions in young adults are weak indicators of what they will do sexually.307
In other words, teens may promise and sincerely desire to avoid sex, but in actuality many will fail to do so.
The administration’s promotion of abstinence appears to be based solely on faith or moral principle. A
public health policy based solely on abstinence has not been shown to be eﬀective.308 Simulation studies
have indicated that given likely compliance rates, the promotion of abstinence may possibly yield a similar
eﬃcacy rate when compared to condoms for preventing STDs.309 Further, the negative eﬀects, if any, of
302See, e.g., President George W. Bush, President Discusses Welfare Reform and Job Training, Address before the Chamber
of Commerce (Feb. 27, 2002), at http://www.whitehouse.gov/news/releases/2002/02/print/20020227-5.html.
303Rep. Henry A. Waxman, U.S. House of Representatives, Committee on Government Reform, Politics
and Science in the Bush Administration, House Investigative Rep., at n. 10 & 11 (Updated Nov. 13, 2003),
at http://www.house.gov/reform/min/politicsandscience/pdfs/pdf politics and science rep.pdf, citing Ari Fleischer, Press
Brieﬁng at the White House (Jan. 27, 2003), at http://www.whitehouse.gov/news/releases/2003/01/20030127-2.html.
http://www.house.gov/reform/min/politicsandscience/pdfs/pdf politics and science rep.pdf
304Waxman, supra note 306, at http://www.house.gov/reform/min/politicsandscience/pdfs/pdf politics and science rep.pdf.
305Id. at 4.http://www.house.gov/reform/min/politicsandscience/pdfs/pdf politics and science rep.pdf. at page 4
306Id. at 5; see also D. Kirby, National Campaign to Prevent Teen Pregnancy, Emerg-
ing Answers: Research Findings on Programs to Reduce Teen Pregnancy 88 (May
2001).http://www.house.gov/reform/min/politicsandscience/pdfs/pdf politics and science rep.pdf
307
308J.D. Fortenberry, Editorial: The Limits of abstinence-only in preventing sexually transmitted infections, 36 J. of Adoles-
cent Health 269, 269-270 (2005); see also, Kirby, supra note 309, at 88 (“[T]here do not currently exist any abstinence-only
programs with reasonably strong evidence that they actually delay the initiation of sex or reduce its frequency”).
309S.D. Pinkerton, A relative risk-based, disease-speciﬁc deﬁnition of sexual abstinence failure rates in Health Educ. Be-
45abstinence promotion are not known.
A recent paper by two sociologists310 has shown that virginity pledges, a form of promoting abstinence,
are not eﬀective in lowering STD infection rates in adolescents.311 Virginity pledges, sponsored by the
organization “True Love Waits,” typically involve teenagers publicly promising their parents and community
not to have sex before marriage.312 The pledger then receives a ring or other jewelry to commemorate his
or her pledge.313
Most pledgers break their promise – of those pledgers who have had sex, only 12% waited until marriage in
contrast to 1% of non-pledgers.314 An earlier study by the same authors does in fact indicate that virginity
pledgers as a group do not have sex until they have attained an older age on average than those who do
not pledge.315 Relative to their non-pledge counterparts, pledgers have fewer sex partners and are sexually
active for shorter time periods.316 Data reveals that up to 25% of consistent pledgers remain virgins until
age twenty-ﬁve and that pledgers marry younger than non-pledgers.317 It appears that pledgers as opposed
to non-pledgers may be exposed to less risk of contracting STDs because on average they have sex with fewer
partners and therefore reduce a signiﬁcant risk component of STD transmission.
Based on a signiﬁcant reduction in exposure to risk factors, one might expect pledgers to have lower STDs
havior, at ch. 28, 10-20 (2001).
310H. Br¨ uckner & P.S. Bearman, After the promise: the STD Consequences of adolescent virginity pledges, 36 J. Adolescent
Health 271-278 (2005).
311Id.
312Id.
313See, for example, Lifeway, Biblical Solutions for Life, Leaders Tools – Ring Ceremony, at
http://www.lifeway.com/tlw/ldr tools ceremony.asp. By 1995, an estimated 2.2 million adolescents (12% of all adoles-
cents) had taken such pledges.
314Br¨ uckner, supra note 313, at 275.
315Id. at 859-912.
316Id. at 271-278. Female pledgers have an average of 1.9 sex partners and are sexually active for 4.2 years compared to their
non-pledge counterparts who have an average of 2.7 sex partners and are sexually active for 5.9 years. Id. at 277.
317Id. at 271-278; table 3 at 275.
46rates than non-pledgers. Despite such a theoretical assumption, the data shows that in reality pledging has
no statistically signiﬁcant eﬀect on STD rates.318 As a possible explanation for this surprising contradiction,
the authors cite data showing that pledgers are less likely to use condoms during intercourse or to be tested
and treated for STDs.319 In addition, virginity pledgers have higher rates of oral and/or anal sex than
their non-pledge counterparts.320 The authors conclude that given equivalent STD rates among pledgers
and non-pledgers, “abstinence as intervention may not be the optimal approach” to preventing STDs among
adolescents.321 Among children and young adults, the debate whether to teach abstinence or safer sex,
including condom use, has not signiﬁcantly changed since the early 20th century.322
VII. Conclusion
Promoting abstinence rather than condom use is akin to recommending self-disciplined and unassisted so
called “cold-turkey” tactics to deal with smoking habits and self-guided dieting to deal with obesity. Both
smoking-related diseases and obesity are widespread public health problems caused by unhealthy lifestyles,
which can be ameliorated if not eliminated by life-style changes. In principle, self-control and discipline
could lead to cheap and lasting changes in harmful behavior. A cursory glance at today’s society reveals that
such disciplined life-style choices are not headed by many, despite widely known risks. Neither a conspicuous
Surgeon General’s warning advising smokers to stop smoking nor a glaringly apparent health risk associated
with both smoking and obesity has led to a signiﬁcant reduction in smokers or wide spread acceptance of
healthy dieting. If one were to measure the eﬃcacy of dieting by those who adhere to a diet, then it is 100%.
If one were to measure the eﬃcacy of dieting accounting for long-term success rates of all of those that begin
318Id. For instance, the study showed that non-pledgers (n=9072) had a 26.5% incidence of HPV infection, while consistent
pledgers (n =777) had a 26.7% infection rate. Id.
319Id.
320Id.
321Id. at 271.
322See J.P. Moran, Teaching Sex: The Shaping of Adolescence in the 20th Century (Harvard Univ. Press 2000); also
see Fortenberry, supra note 311, at 269-270.
47a diet, some of which fail, then the ﬁgures are much more disappointing.
Such a phenomenon is identical to what one should expect in connection with abstinence. Thus, abstinence
is completely eﬀective, provided that one embarking upon the mission will perfectly follow the “diet.” Absti-
nence is far less eﬀective, however, when one factors in individual human fallibility across over the long-term.
In sum, the personal choice of abstinence may be eﬀective, but it might not be eﬀective as a viable public
health policy.
Both history and data strongly suggest that abstinence alone does not work to prevent pregnancy or STDs.
However, given the strong moral opposition many conservatives have to promoting condoms and safer sex,
the issue is likely to be a subject of political debate for years to come.
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Table 5-1. Comparison of International Latex Condom Standards/Speciﬁcations, 1997
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Table 1: from http://www.4parents.gov/talktopics/table.htm
Bacterial Sexually Transmitted
Diseases
Viral Sexually Transmitted
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STDs
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chronic
low
stom-
ach
pain,
pelvic
in-
fec-
tion/fever,
in-
fer-
til-
ity
may
re-
sult
(mostly
in
women),
can
in-
fect
ba-
bies
Painless
chancre
(sore),
untreated
it can
spread to
the brain
and/or
heart,
can cause
birth
defects
and
lesions on
infants’
skin and
other
problems
with their
organs
Painful
blisters,
fever,
swollen
glands,
symptoms
reoccur
throughout
life, can
infect
babies
Few early
symptoms,
may cause
warts, can
cause
cancer of
the cervix,
anus and
penis, can
infect
babies
No early
symp-
toms,
destroys
immune
system,
multiple
severe
infec-
tions, no
known
cure,
fatal
illness,
can
infect
babies
54How can it
be spread?
Oral,
anal and
vaginal
sex, and
mother
to child
Oral, anal and
vaginal sex, and
mother to child
Oral,
anal
and
vagi-
nal
sex,
con-
tact
with
sores,
mother
to
child
Oral,
anal
and
vagi-
nal
sex,
con-
tact
with
in-
fected
skin,
mother
to
child
Anal
and
vagi-
nal
sex,
con-
tact
with
in-
fected
skin,
mother
to
child
(rare)
Oral,
anal
and
vagi-
nal
sex,
IV
drug
use,
mother
to
child
Can
con-
doms
help
if
al-
ways
used
(100%
of
the
time
and
cor-
rectly)?
Condom
use
is
as-
so-
ci-
ated
with
some
de-
creased
risk.
(Risk
re-
duc-
tion
is
50%
or
less.)
Condom
use
is
as-
so-
ci-
ated
with
some
de-
creased
risk.
(Risk
re-
duc-
tion
is
50%
or
less.)
Condom
use is as-
sociated
with
some
decreased
risk.
(Risk
reduction
is 50% or
less.)
Condom
use is
associated
with some
decreased
risk. (Risk
reduction
is 50% or
less.)*
No
evidence
that
condom
use reduces
risk of
HPV
infection.
Some
evidence
that
condoms
reduce the
risk of
HPV-
associated
diseases.
Condom
use de-
creases
the risk
of
HIV/AIDS
trans-
mission
by
approxi-
mately
85%.
55How many
infected
teens are
reported?
3-14%
of
women
age
15-24
who
visited
family
planning
clinics
(2002)
0.1 to 2.8% of
women age
15-24 who
visited family
planning clinics
(based on
reporting states)
In 2002,
there
were
about
350 cases
of
primary
and
secondary
syphilis in
15-19 yr
olds
The most
recent
estimates
show that
depending
on
race/ethnicity,
4.5% -
8.8%
percent of
teens
12-19 are
infected
with
Herpes
About 28
to 46% of
women
under 25
are
estimated
to be
infected
with HPV
By the
end of
2002,
about
36,000
individu-
als age
13 to 24
had been
diag-
nosed
with
AIDS
What are
the treat-
ments?
Antibiotics
(perma-
nent
damage
may
have oc-
curred)
Antibiotics
(permanent
damage may
have occurred)
Antibiotics
(perma-
nent
damage
may have
occurred)
Symptom
control,
but no cure
Monitor
through
pap smears
for cancer
changes,
Surgery for
warts and
cervical
growths
Symptom
control
with
AIDS
Medicines
(an-
tiretrovi-
ral
drugs)
No Cure
56Notes:
*This
takes into
account as
yet unpub-
lished
data,
which
were
presented
at the
2002
National
STD Con-
ference,
sponsored
by the
CDC. See
below for
citation.
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